<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002837.pub2" GROUP_ID="UPPERGI" ID="729300071915450623" MERGED_FROM="" MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness" REVIEW_NO="14" REVMAN_SUB_VERSION="5.0.18" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness">
<TITLE>Enteral versus parenteral nutrition for acute pancreatitis</TITLE>
<CONTACT MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness"><PERSON ID="16623" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mohammed</FIRST_NAME><LAST_NAME>Al-Omran</LAST_NAME><POSITION>Associate Professor &amp; Consultant Vascular Surgeon</POSITION><EMAIL_1>malomran@ksu.edu.sa</EMAIL_1><URL>www.vascular-ksu.org</URL><ADDRESS><DEPARTMENT>Department of Surgery and Peripheral Vascular Disease Research Chair</DEPARTMENT><ORGANISATION>College of Medicine, King Saud University</ORGANISATION><ADDRESS_1>P.O.Box 7805(37)</ADDRESS_1><CITY>Riyadh</CITY><ZIP>11472</ZIP><COUNTRY CODE="SA">Saudi Arabia</COUNTRY><PHONE_1>9661- 467-1575</PHONE_1><PHONE_2>+9661-467-9493</PHONE_2><FAX_1>+1 416 598 7755</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness"><PERSON ID="16623" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mohammed</FIRST_NAME><LAST_NAME>Al-Omran</LAST_NAME><POSITION>Associate Professor &amp; Consultant Vascular Surgeon</POSITION><EMAIL_1>malomran@ksu.edu.sa</EMAIL_1><URL>www.vascular-ksu.org</URL><ADDRESS><DEPARTMENT>Department of Surgery and Peripheral Vascular Disease Research Chair</DEPARTMENT><ORGANISATION>College of Medicine, King Saud University</ORGANISATION><ADDRESS_1>P.O.Box 7805(37)</ADDRESS_1><CITY>Riyadh</CITY><ZIP>11472</ZIP><COUNTRY CODE="SA">Saudi Arabia</COUNTRY><PHONE_1>9661- 467-1575</PHONE_1><PHONE_2>+9661-467-9493</PHONE_2><FAX_1>+1 416 598 7755</FAX_1></ADDRESS></PERSON><PERSON ID="646727E582E26AA20125F76B16AF5736" ROLE="AUTHOR"><FIRST_NAME>Zaina</FIRST_NAME><MIDDLE_INITIALS>H</MIDDLE_INITIALS><LAST_NAME>AlBalawi</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Associate Researcher</POSITION><EMAIL_1>Zaina7rb@yahoo.com</EMAIL_1><EMAIL_2>zalbalaw@ualberta.ca</EMAIL_2><MOBILE_PHONE>+966 503 278 124</MOBILE_PHONE><ADDRESS><DEPARTMENT>Sheikh Abdullah S. Bahamdan Research Chair for Evidence-Based Health Care and Knowledge Translation</DEPARTMENT><ORGANISATION>College of Medicine, King Saud University</ORGANISATION><ADDRESS_1>P.O. Box 68639</ADDRESS_1><CITY>Riyadh</CITY><ZIP>11537</ZIP><REGION>Central</REGION><COUNTRY CODE="SA">Saudi Arabia</COUNTRY><PHONE_1>+966 1 442 1900</PHONE_1><FAX_1>+966 1 480 0480</FAX_1></ADDRESS></PERSON><PERSON ID="11A585CB82E26AA200CF03848E697979" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mariam</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Tashkandi</LAST_NAME><POSITION>Research Student</POSITION><EMAIL_1>mariam.tashkandi@gmail.com</EMAIL_1><URL>www.clubfootarabia.com</URL><MOBILE_PHONE>+14165662727</MOBILE_PHONE><ADDRESS><DEPARTMENT>Applied Health Research Centre</DEPARTMENT><ORGANISATION>LKSKI St. Michael's Hospital</ORGANISATION><ADDRESS_1>10 Queens Quay - 1211</ADDRESS_1><CITY>Toronto</CITY><ZIP>M5J2R9</ZIP><REGION>Ontario</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+14165662727</PHONE_1></ADDRESS></PERSON><PERSON ID="9A9988C482E26AA201DB0C7EB3DDD87B" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Lubna</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Al-Ansary</LAST_NAME><SUFFIX>MSc, FRCGP</SUFFIX><POSITION>Associate Professor and Consultant</POSITION><EMAIL_1>lansary@yahoo.com</EMAIL_1><EMAIL_2>ebhc_chair@ksu.edu.sa</EMAIL_2><URL>http://www.ebhc-ksu.com/</URL><MOBILE_PHONE>+966505489823</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Family &amp; Community Medicine, Holder of "Shaikh Abdullah S. Bahamdan" Research Chair for Evidence-Based Health Care and Knowledge Translation</DEPARTMENT><ORGANISATION>College of Medicine, King Saud University</ORGANISATION><ADDRESS_1>P.O.Box 2925</ADDRESS_1><CITY>Riyadh</CITY><ZIP>11461</ZIP><COUNTRY CODE="SA">Saudi Arabia</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness">
<UP_TO_DATE>
<DATE DAY="3" MONTH="10" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="11" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="11" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness"><DATE DAY="5" MONTH="10" YEAR="2010"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>

</WHATS_NEW>
<HISTORY MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness"><WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2010-10-05 15:54:27 +0200" MODIFIED_BY="Karin Dearness">
<DATE DAY="12" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>Updated, new studies found, additions to the methods section, conclusions changed and additional authors contributed to the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-01 05:57:03 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-09-16 14:56:53 +0100" MODIFIED_BY="Cathy Bennett">
<DATE DAY="19" MONTH="7" YEAR="2004"/>
<DESCRIPTION>
<P>Minor update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-09-16 14:56:54 +0100" MODIFIED_BY="Cathy Bennett">
<DATE DAY="2" MONTH="7" YEAR="2004"/>
<DESCRIPTION>
<P>New studies sought but none found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2009-09-16 14:56:57 +0100" MODIFIED_BY="Cathy Bennett">
<DATE DAY="30" MONTH="10" YEAR="2002"/>
<DESCRIPTION>
<P>Substantive amendment.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-06-27 17:55:10 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2009-06-27 17:54:54 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-06-27 17:54:54 +0100" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Upper Gastrointestinal and Pancreatic Diseases Group</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION>
<P>Conducting the search, and assistance in retrieving full text for relevant articles.</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2009-06-27 17:55:10 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-06-27 17:55:10 +0100" MODIFIED_BY="[Empty name]">
<NAME>J.W. Scott Health Sciences Library at University of Alberta</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION>
<P>Assistance in retrieving full text for relevant articles.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-11-04 11:25:06 +0000" MODIFIED_BY="Jan Lilleyman">
<SUMMARY MODIFIED="2009-11-03 22:19:36 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-09-16 15:32:52 +0100" MODIFIED_BY="Cathy Bennett" NOTES="&lt;p&gt;This sentence does not read correctly - needs amending&lt;/p&gt;" NOTES_MODIFIED="2009-09-16 15:32:52 +0100" NOTES_MODIFIED_BY="Cathy Bennett">Nutritional support, through the intestine (enteral) versus by injection (parenteral) for people with acute pancreatitis</TITLE>
<SUMMARY_BODY MODIFIED="2009-11-03 22:19:36 +0000" MODIFIED_BY="[Empty name]">
<P>The pancreas is a gland that lies behind the stomach. It produces enzymes that help digestion. Acute pancreatitis is an inflammation in the pancreas which causes severe pains in the stomach. Extra nutrition is needed to recover. However the pancreas needs rest in order to repair. Nutrition must therefore be given either by a tube into the intestines (enteral) or by injection (parenteral). This review found that patients with acute pancreatitis receiving enteral nutrition have fewer episodes of death, systemic infections, multiple organ failure and operative interventions. This data suggests that EN should be considered the standard of care for patients with acute pancreatitis requiring nutritional support.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-09-16 15:06:03 +0100" MODIFIED_BY="Cathy Bennett">
<ABS_BACKGROUND MODIFIED="2009-07-03 15:37:03 +0100" MODIFIED_BY="[Empty name]">
<P>Acute pancreatitis creates a catabolic stress state promoting a systemic inflammatory response and nutritional deterioration. Adequate supply of nutrients plays an important role in recovery. Total parenteral nutrition (TPN) has been standard practice for providing exogenous nutrients to patients with severe acute pancreatitis. However, recent data suggest that enteral nutrition (EN) is not only feasible, but safer and more effective.Therefore, we sought to update our systematic review to re-evaluate the level of evidence.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2009-09-16 14:57:53 +0100" MODIFIED_BY="Cathy Bennett">
<P>To compare the effect of TPN versus EN on mortality, morbidity and length of hospital stay in patients with acute pancreatitis.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-09-16 15:06:03 +0100" MODIFIED_BY="Cathy Bennett">
<P>Trials were identified by computerized searches of The Cochrane Controlled Trials Register, MEDLINE, and EMBASE. Additional studies were identified by searching Scisearch, bibliographies of review articles and identified trials. The search was undertaken in August 2000 and updated in September 2002, October 2003, November 2004 and November 2008. No language restrictions were applied.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2009-07-03 15:27:41 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized clinical trials comparing TPN to EN in patients with acute pancreatitis.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-07-03 15:28:37 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers independently abstracted data and assessed trial quality. A standardized form was used to extract relevant data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-07-23 17:28:57 +0100" MODIFIED_BY="[Empty name]">
<P>Eight trials with a total of 348 participants were included. Comparing EN to TPN for acute pancreatitis, the relative risk (RR) for death was 0.50 (95% CI 0.28 to 0.91), for multiple organ failure (MOF) was 0.55 (95% CI 0.37 to 0.81), for systemic infection was 0.39 (95% CI 0.23 to 0.65), for operative interventions was 0.44 (95% CI 0.29 to 0.67), for local septic complications was 0.74 (95% CI 0.40 to 1.35), and for other local complications was 0.70 (95% CI 0.43 to 1.13). Mean length of hospital stay was reduced by 2.37 days in EN vs TPN groups (95% CI -7.18 to 2.44). Furthermore, a subgroup analysis for EN vs TPN in patients with severe acute pancreatitis showed a RR for death of 0.18 (95% CI 0.06 to 0.58) and a RR for MOF of 0.46 (95% CI 0.16 to 1.29).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-07-16 13:18:30 +0100" MODIFIED_BY="[Empty name]">
<P>In patients with acute pancreatitis, enteral nutrition significantly reduced mortality, multiple organ failure, systemic infections, and the need for operative interventions compared to those who received TPN. In addition, there was a trend towards a reduction in length of hospital stay. These data suggest that EN should be considered the standard of care for patients with acute pancreatitis requiring nutritional support.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-11-03 22:31:22 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2009-09-16 15:01:59 +0100" MODIFIED_BY="Cathy Bennett">
<CONDITION MODIFIED="2009-09-16 15:01:17 +0100" MODIFIED_BY="Cathy Bennett">
<P>Acute pancreatitis is a common hypermetabolic, hyperdynamic disease process of variable severity that has multiple etiologies and creates a catabolic stress state promoting a systemic inflammatory response and nutritional deterioration (<LINK REF="REF-Havala-1989" TYPE="REFERENCE">Havala 1989</LINK>; <LINK REF="REF-Steinberg-1994" TYPE="REFERENCE">Steinberg 1994</LINK>).</P>
<P>In severe acute pancreatitis, the inflammatory response following necrosis or inflammation of the pancreas and retroperitoneal tissues leads to increased caloric requirement and loss of protein mass (<LINK REF="REF-Havala-1989" TYPE="REFERENCE">Havala 1989</LINK>). This, combined with absence of oral intake, promotes progressive nutritional deterioration and persistent negative nitrogen balance that appears to be associated with a higher mortality rate as a result of loss of function and structural integrity of vital organs (<LINK REF="REF-Bradley-1993" TYPE="REFERENCE">Bradley 1993</LINK>; <LINK REF="REF-Pisters-1992" TYPE="REFERENCE">Pisters 1992</LINK>; <LINK REF="REF-Sitzmann-1989" TYPE="REFERENCE">Sitzmann 1989</LINK>).</P>
<P>In critically ill patients, the gastrointestinal tract serves as a potential source of fuel for the immuno-inflammatory response, since a metabolically deprived gut absorbs endotoxin and other bacterial products, which in turn stimulate endogenous cytokines (<LINK REF="REF-Fink-1991" TYPE="REFERENCE">Fink 1991</LINK>). Similar mechanisms have been shown in experimental acute pancreatitis to be a cause of the inflammatory response (<LINK REF="REF-Runkel-1991" TYPE="REFERENCE">Runkel 1991</LINK>; <LINK REF="REF-Ryan-1993" TYPE="REFERENCE">Ryan 1993</LINK>). It has also been shown that intestinal permeability increases in patients with severe acute pancreatitis (<LINK REF="REF-Ammori-1999" TYPE="REFERENCE">Ammori 1999</LINK>). Failure to use the gut may lead to the development of nosocomial infections, sepsis, and organ failure (<LINK REF="REF-Hancke-1987" TYPE="REFERENCE">Hancke 1987</LINK>; <LINK REF="REF-Helton-1990" TYPE="REFERENCE">Helton 1990</LINK>; <LINK REF="REF-Lange-1987" TYPE="REFERENCE">Lange 1987</LINK>; <LINK REF="REF-Russel-1983" TYPE="REFERENCE">Russel 1983</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2009-09-16 15:01:33 +0100" MODIFIED_BY="Cathy Bennett">
<P>Nutritional status can deteriorate rapidly in patient with severe acute pancreatitis (<LINK REF="REF-Bradley-1993" TYPE="REFERENCE">Bradley 1993</LINK>; <LINK REF="REF-Havala-1989" TYPE="REFERENCE">Havala 1989</LINK>; <LINK REF="REF-Pisters-1992" TYPE="REFERENCE">Pisters 1992</LINK>; <LINK REF="REF-Sitzmann-1989" TYPE="REFERENCE">Sitzmann 1989</LINK>), and subsequent recovery may be prolonged in the severely depleted patient (<LINK REF="REF-Keys-1950" TYPE="REFERENCE">Keys 1950</LINK>). Thus, early nutritional support plays an important role in the adjunctive management of these patients to ensure optimum recovery (<LINK REF="REF-Kalfarentzos-1991" TYPE="REFERENCE">Kalfarentzos 1991</LINK>).</P>
<P>Total parenteral nutrition (TPN) has been the standard practice for providing exogenous nutrients to patients with severe acute pancreatitis, while avoiding pancreatic stimulation (<LINK REF="REF-Goodgame-1977" TYPE="REFERENCE">Goodgame 1977</LINK>; <LINK REF="REF-Grant-1984" TYPE="REFERENCE">Grant 1984</LINK>; <LINK REF="REF-Kalfarentzos-1991" TYPE="REFERENCE">Kalfarentzos 1991</LINK>; <LINK REF="REF-VanGossum-1988" TYPE="REFERENCE">VanGossum 1988</LINK>). However, TPN is associated with certain disadvantages including cost (<LINK REF="REF-Twomey-1985" TYPE="REFERENCE">Twomey 1985</LINK>), risk of catheter sepsis, and metabolic and electrolyte disturbances (<LINK REF="REF-Goodgame-1977" TYPE="REFERENCE">Goodgame 1977</LINK>; <LINK REF="REF-Grant-1984" TYPE="REFERENCE">Grant 1984</LINK>; <LINK REF="REF-Kalfarentzos-1991" TYPE="REFERENCE">Kalfarentzos 1991</LINK>; <LINK REF="REF-VanGossum-1988" TYPE="REFERENCE">VanGossum 1988</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2009-09-16 15:01:34 +0100" MODIFIED_BY="Cathy Bennett">
<P>Early enteral nutrition (EN) can maintain the integrity and function of intestinal mucosa (<LINK REF="REF-Buchman-1995" TYPE="REFERENCE">Buchman 1995</LINK>; <LINK REF="REF-Maxton-1989" TYPE="REFERENCE">Maxton 1989</LINK>). On the other hand, TPN may lead to malfunction of intestinal mucosal barrier, which may promote gut origin sepsis (<LINK REF="REF-Saadia-1990" TYPE="REFERENCE">Saadia 1990</LINK>). This may be secondary to gut atrophy, or due to the absence of glutamine, which is not included in conventional solutions (<LINK REF="REF-Gardiner-1995" TYPE="REFERENCE">Gardiner 1995</LINK>).</P>
<P>Studies of other immuno-inflammatory conditions associated with trauma (<LINK REF="REF-McClave-1986" TYPE="REFERENCE">McClave 1986</LINK>), thermal injury (<LINK REF="REF-Alexender-1980" TYPE="REFERENCE">Alexender 1980</LINK>), and major surgery (<LINK REF="REF-Moore-1992" TYPE="REFERENCE">Moore 1992</LINK>) have shown that septic morbidity can be reduced by early introduction of EN.</P>
<P>One of the most important aspects of nutritional support in acute pancreatitis is to put the pancreas to rest, to avoid its stimulation (<LINK REF="REF-Povoski-1995" TYPE="REFERENCE">Povoski 1995</LINK>). Pancreatic stimulation can be avoided if enteral nutrition is delivered to the small intestine distal to the ligament of Treitz, since nutrients infused into the jejunum result in minimal or negligible stimulation (<LINK REF="REF-Corcoy-1988" TYPE="REFERENCE">Corcoy 1988</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2009-09-16 15:01:59 +0100" MODIFIED_BY="Cathy Bennett">
<P>EN has the advantages of being less expensive and having the potential for protecting the gut barrier (<LINK REF="REF-Scolapio-1999" TYPE="REFERENCE">Scolapio 1999</LINK>). However, EN has limitations that may reduce its applicability. These include the risk of proximal tube migration with subsequent pancreatic stimulation resulting in aggravation of pancreatitis, and the presence of ileus (<LINK REF="REF-McClave-1998" TYPE="REFERENCE">McClave 1998</LINK>; <LINK REF="REF-Scolapio-1999" TYPE="REFERENCE">Scolapio 1999</LINK>).</P>
<P>Recent data suggest that enteral nutrition is not only feasible, but safer and more effective than TPN in patients with acute pancreatitis. A number of national and international societies recommend EN, but these recommendations are mostly based on randomised controlled trials (<LINK REF="REF-Banks-2006" TYPE="REFERENCE">Banks 2006</LINK>; <LINK REF="REF-British-Society-of-Gastroenterology-2005" TYPE="REFERENCE">British Society of Gastroenterology 2005</LINK>).<B> </B>Therefore, we sought to update our systematic review to re-evaluate the level of evidence.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>The primary objective was to conduct a systematic review to compare the effect of total parenteral nutrition (TPN) versus enteral nutrition (EN) on mortality, morbidity and length of hospital stay in patients with acute pancreatitis.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-09-16 15:11:24 +0100" MODIFIED_BY="Cathy Bennett">
<SELECTION_CRITERIA MODIFIED="2009-09-16 15:04:29 +0100" MODIFIED_BY="Cathy Bennett">
<CRIT_STUDIES MODIFIED="2009-09-16 15:03:14 +0100" MODIFIED_BY="Cathy Bennett">
<P>Randomized clinical trials, in which nutritional support with TPN was compared to EN in patients with acute pancreatitis.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Patients with a diagnosis of acute pancreatitis established by clinical presentation and elevated serum amylase. The study should include a recognized assessment of acute pancreatitis severity such as Ranson's criteria, Acute Physiology and Chronic Health Evaluation (APACHE) II score (<LINK REF="REF-Knaus-1985" TYPE="REFERENCE">Knaus 1985</LINK>), Imrie classification (<LINK REF="REF-Blamey-1984" TYPE="REFERENCE">Blamey 1984</LINK>), C-reactive protein concentration, or Balthazar CT scan score (<LINK REF="REF-Balthazar-1990" TYPE="REFERENCE">Balthazar 1990</LINK>).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2009-09-16 15:04:07 +0100" MODIFIED_BY="Cathy Bennett">
<P>Total parenteral nutrition (TPN) delivered through a central or peripheral venous line.</P>
<P>Enteral nutrition (EN) delivered through a nasoenteric feeding tube placed endoscopically or under fluoroscopy down into the jejunum at or below the level of ligament of Treitz, or confirmed radiologically after placement.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2009-09-16 15:04:29 +0100" MODIFIED_BY="Cathy Bennett">
<P>We considered trials if any of the following clinical outcomes were reported:</P>
<OL>
<LI>Death</LI>
<LI>Length of hospital stay</LI>
<LI>Systemic inflammatory response syndrome (SIRS)</LI>
<LI>Multiple organ failure (MOF)</LI>
<LI>Operative intervention</LI>
<LI>Systemic infection (septicemia, urinary tract infection (UTI), pneumonia, line infection)</LI>
<LI>Local septic complications (pancreatic abscess formation, infected necrosis)</LI>
<LI>Other local complications (fluid collection, pseudocyst, sterile pancreatic necrosis, fistula)</LI>
<LI>Protection of gut mucosal barrier as estimated, indirectly, by changes in the serum level of IgM anti-endotoxin core antibody (Endo CAb), total antioxidant capacity (TAC), Tumor Necrosis Factor (TNF), or Interlukin-6 (IL-6)</LI>
</OL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-09-16 15:09:49 +0100" MODIFIED_BY="Cathy Bennett">
<ELECTRONIC_SEARCHES MODIFIED="2009-09-16 15:09:49 +0100" MODIFIED_BY="Cathy Bennett">
<P>The following bibliographic databases were searched in order to identify relevant primary studies:</P>
<UL>
<LI>Cochrane Controlled Trials Register (CCTR)</LI>
<LI>MEDLINE</LI>
<LI>EMBASE</LI>
</UL>
<P>Trials were identified by searching MEDLINE 1966-2008 November week 3, The Cochrane Library 4th quarter 2008, EMBASE 1980-2008 week 49. We did not confine our search to English language publications. Searches in all databases were updated in September 2002, October 2003, November 2004 and December 2008.<BR/>The Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE, sensitivity maximising version, Ovid format (<LINK REF="REF-Lefebvre-2008" TYPE="REFERENCE">Lefebvre 2008</LINK>), was combined with the search terms to identify randomized controlled trials in MEDLINE. The MEDLINE search strategy was adapted for use in the other databases searched (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-09-16 15:09:48 +0100" MODIFIED_BY="Cathy Bennett">
<P>Additional studies were identified and included where relevant by searching Scisearch, the bibliographies of review articles and identified trials, and personal files. For ongoing trials, the following web site was searched: www.clinicaltrials.gov.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-09-16 15:11:24 +0100" MODIFIED_BY="Cathy Bennett">
<STUDY_SELECTION MODIFIED="2009-08-10 02:50:02 +0100" MODIFIED_BY="[Empty name]">
<P>All retrieved studies' titles were scanned independently by two authors (MFT and ZHB), to assess whether it should be included or excluded. Disagreement was solved by consensus between them both, and full articles were retrieved for those found to be relevant. To avoid over-representing duplicate studies in the review, duplicate publications were excluded.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2009-07-03 14:22:08 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers (MFT and ZHB) extracted data using a standard form to record data independently. Recorded data were cross checked by the reviewers. If an agreement could not be reached by consensus, the third author (MA) was consulted. The data were entered into RevMan (version 5.0.20) for analysis. The following parameters were extracted: Number of deaths, SIRS, MOF, operative interventions, local septic complications (pancreatic abscess formation, infected necrosis), other local complications (fluid collection, pseudocyst, sterile pancreatic necrosis, fistula), systemic infection (septicemia, UTI, pneumonia, line infection), protection of gut mucosal barrier parameters, and length of hospital stay in days.<BR/>
</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2009-09-16 15:08:35 +0100" MODIFIED_BY="Cathy Bennett">
<P>Two authors (MFT and ZHB) independently assessed the selected trials for methodological quality using The Cochrane Collaboration method for assessing risk of bias (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). This set of criteria is based on evidence of associations between overestimates of effect and high risk of bias of the article such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. The categories are defined below:</P>
<P>YES - low risk of bias<BR/>NO - high risk of bias<BR/>UNCLEAR - uncertain risk of bias</P>
<P>We resolved disagreements by consensus, or, if this failed, by consulting a third author (MA).<BR/>
</P>
<P>Other validity criteria to assess studies included the following:</P>
<UL>
<LI>baseline comparability of treatment groups (Severity score)</LI>
<LI>presence of inclusion and exclusion criteria</LI>
<LI>intervention described in detail</LI>
<LI>definition of outcomes</LI>
<LI>stated time for outcome assessment</LI>
<LI>stated indications for further interventions</LI>
</UL>
<P>We planned on assessing for reporting and publication bias by funnel plots if ten or more studies were available for an outcome. This minimum number of studies was decided upon because if asymmetry were evident, tests for funnel plot asymmetry would have low power to distinguish chance from real asymmetry (<LINK REF="REF-Sterne-2008" TYPE="REFERENCE">Sterne 2008</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2009-09-16 15:11:24 +0100" MODIFIED_BY="Cathy Bennett">
<P>The extracted data from the trials was combined by calculating a pooled estimate of the relative risk and 95% confidence interval for dichotomous data using fixed-effects model if the data was homogenous and a random-effects model if the data was heterogenous indicated by a P value &lt;0.1. Where continuous data outcomes were measured in a standard way across studies, the mean difference (and 95% confidence interval) was calculated; using a fixed-effects model for homogenous data and a random-effects model for heterogenous data. RevMan Software (version 5.0.20) was used for statistical analysis.</P>
</EFFECT_MEASURES>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-11-03 22:26:53 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2009-11-03 22:23:26 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2009-07-16 13:43:12 +0100" MODIFIED_BY="[Empty name]">
<P>The updated search generated 779 studies. No relevant ongoing trials were found upon searching www.clinicaltrials.gov. After screening, eleven were considered to be potentially eligible and from these, five were excluded. Six randomized clinical trials comparing EN and TPN fulfilled the criteria for consideration into the update of this review. In total, this review now includes eight trials comparing EN to TPN for acute pancreatitis.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2009-11-03 22:23:26 +0000" MODIFIED_BY="[Empty name]">
<P>For details of included studies see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>We included eight randomized controlled trials of published studies. Countries of publication varied with three from North America (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>), one from Greece (<LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>), Russia (<LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>), Spain (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>), United Kingdom (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>) and Hungary (<LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>); all were in English. We contacted authors of trials who did not report means and/or standard deviations of continuous outcomes such as length of hospital stay or measurements of gut mucosal barrier protection (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>). Two replied (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>), but only the latter was able to provide the missing data, and it was included. The eight included trials involved a total of 348 participants.</P>
<P>All these studies compared EN with TPN for acute pancreatitis. The number of participants included in each trial ranged between 17 and 89 and their ages ranged between 21 and 91 years.</P>
<SUBSECTION>
<HEADING LEVEL="4">Inclusion criteria</HEADING>
<P>Inclusion criteria were fairly consistent among trials in diagnosis of acute pancreatitis that is, clinical signs with an elevated serum marker. Only one study (<LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>) did not mention how acute pancreatitis was diagnosed. All the trials included males and females except one trial that included only males (<LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>). Among these eight trials, five only included particpants with severe acute pancreatitis (SAP) (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>), and one included a subgroup analysis of SAP patients (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>). Criteria for diagnosing severity were variable, the most commonly used was the Acute Physiology and Chronic Health Evaluation (APACHE II) score followed by Ransons criteria.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Exclusion criteria</HEADING>
<P>These varied, with three studies excluding pregnant women (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>), three others excluded young patients younger than 18 years old (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>) and one less than 16 years of age (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>). Another common feature to exclude participants was inability to initiate enteral feeding (<LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>; <LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention</HEADING>
<P>For the enteral group, the nasojejunal tube was inserted fluoroscopically or endoscopically in all the trials except two (<LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>), where the tube was inserted blindly and then confirmed by radiology. The TPN group had nutrition supplied through a central line. Two trials, in addition to using a central line in some patients, used a peripheral line for nutrition in others (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome measurements</HEADING>
<P>Outcomes varied, with mortality being consistent among them all (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2009-07-16 13:57:23 +0100" MODIFIED_BY="[Empty name]">
<P>In total, eight studies were excluded (<LINK REF="STD-Hernandez_x002d_Aranda1996" TYPE="STUDY">Hernandez-Aranda1996</LINK>; <LINK REF="STD-Windsor-1996" TYPE="STUDY">Windsor 1996</LINK>; <LINK REF="STD-Windsor-1998" TYPE="STUDY">Windsor 1998</LINK>; <LINK REF="STD-Powell-2000" TYPE="STUDY">Powell 2000</LINK>; <LINK REF="STD-Eckerwall-2006" TYPE="STUDY">Eckerwall 2006</LINK>; <LINK REF="STD-Modena-2006" TYPE="STUDY">Modena 2006</LINK>; <LINK REF="STD-Ye-2007" TYPE="STUDY">Ye 2007</LINK>; <LINK REF="STD-Bao-2006" TYPE="STUDY">Bao 2006</LINK> ). The first three were previously excluded from the search generated for the original review in 2000, while the latter four trials were excluded from the search that was done for the latest update of this review. One study was in Chinese and this was found to be initially relevant from its abstract, translation was undertaken and the study was then excluded because both groups were given TPN before initiating EN in the comparison group (<LINK REF="STD-Bao-2006" TYPE="STUDY">Bao 2006</LINK>). One compared TPN with TPN+EN (<LINK REF="STD-Ye-2007" TYPE="STUDY">Ye 2007</LINK> ), the other compared TPN with nutrition delivered through a nasogastric rather than a nasojejunal tube (<LINK REF="STD-Eckerwall-2006" TYPE="STUDY">Eckerwall 2006</LINK>), another compared EN to conventional treatment that did not include TPN (<LINK REF="STD-Powell-2000" TYPE="STUDY">Powell 2000</LINK>), and the final one was not randomized (<LINK REF="STD-Modena-2006" TYPE="STUDY">Modena 2006</LINK>).</P>
<P>Details of exclusion for the remaining studies are described in <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-11-03 22:25:44 +0000" MODIFIED_BY="[Empty name]">
<P>This is illustrated in (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
<ALLOCATION MODIFIED="2009-09-16 15:14:11 +0100" MODIFIED_BY="Cathy Bennett">
<P>Concealment of the allocation process was adequately done in half of the studies (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>). For the other half, three did not report sufficient details to judge and were therefore categorized as being unclear (<LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>; <LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>), and one reported an inadequate method by allocating according to the day of birth (<LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2009-09-16 15:14:24 +0100" MODIFIED_BY="Cathy Bennett">
<P>This was not addressed in any of the studies included. We acknowledge that blinding of the intervention is impossible, even attempts to blind radiologists, for example, would not work since the nasojejunal tube would be apparent on radiological images.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2009-07-02 13:52:44 +0100" MODIFIED_BY="[Empty name]">
<P>In all eight studies, all participants randomised had completed the study and there were no missing data for reported outcomes.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2009-07-02 13:52:55 +0100" MODIFIED_BY="[Empty name]">
<P>All studies included all primary and secondary outcomes described in their introduction and/or methods in the results section in the pre-specified way. One study did not provide details of the statistical methods used in some continuous outcomes, the authors were contacted and provided the missing data (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2009-11-03 22:25:44 +0000" MODIFIED_BY="[Empty name]">
<P>Sources of funding that had involvement of one of their products in the intervention or comparison group were considered to be potential sources of bias if they did not provide further details on the extent of their involvement in the study. Consequently, a concern arose for two studies because of their source of funding (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>). Both trials did not provide any further detail of whether their funding agency had any role in the design or approval of publishing the study. In the other study (<LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>), the trial was stopped early for difficulty in recruitment, compliance and obtaining consent. Their study at that point showed significant difference of cost in favour of the intervention group and reported no deaths in either group. This was also considered to be an unclear contributor to bias because the absence of mortality may have been either due to the low risk population included in the study (mild pancreatitis), or the early termination may have masked it.</P>
<P>In reference to our pre-specified criteria for considering funnel plots, we did not attempt to investigate for publication bias because fewer than ten studies were identified.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-11-03 22:26:53 +0000" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK> for relevant forest plots, and <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK> for a summary of important outcomes and their level of evidence.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Mortality</HEADING>
<P>This is the only outcome reported in all eight studies with a total number of 348 participants. The studies were homogenous and so a fixed-effects model was used. The relative risk (RR) for death was 0.50 (95% CI 0.28 to 0.91; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) (see <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Two studies had no deaths throughout the study period (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>). In one study (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>), they analysed that death in two from the TPN group and four from the EN group occurred after resolution of acute pancreatitis and was attributed to other causes; cancer of the liver, cardiac surgery, squamous cell carcinoma of the pharynx and intracerebral hemorrhage. A meta-analysis performed by excluding those patients resulted in a RR for death of 0.39 (95% CI 0.2 to 0.77; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) (see <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>), being statistically significant in both cases.</P>
<P>Among those eight trials, five included only patients with severe acute pancreatitis (SAP); (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>). Subgroup analysis was done by excluding one of them (<LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>) because not all included participants were assessed for severity. The meta-analysis showed a RR of 0.18 (95% CI 0.06 to 0.58; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>) (see <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Length of hospital stay</HEADING>
<P>Five studies reported this outcome (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>), but only four were included in the meta-analysis with a sample number of 145. Three studies provided sufficient data to be entered in the meta-analysis (<LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>; <LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>), the latter by contacting the author for missing standard devation (SD) figures. One trial, (<LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>) had missing SD, the author was contacted but no reply was received, so this was imputed by calculating the average of the SD of the other three studies in accordance with the recommendation stated in the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2008a" TYPE="REFERENCE">Higgins 2008a</LINK>). The last remaining study (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>) did not report any means or SD, the author was contacted but was unable to provide the missing data, and this study was therefore excluded from this meta-analysis. A fixed-effects model was applied since the studies were homogenous. The MD for length of hospital stay with EN was -2.37 (95% CI -7.18 to 2.44; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>) (see <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>).</P>
<P>Among those four included studies (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>), one included only patients with SAP (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>), and another included a subgroup analysis of patients with SAP for length of hospital stay only (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>). We performed a subgroup analysis including both those trials - including only the subgroup of the latter study - and this resulted in a MD of -6.27 (95% CI -15.40 to 2.87; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>) (see <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Systemic inflammatory response syndrome (SIRS)</HEADING>
<P>This was reported in only one study (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>) where the RR for SIRS was 1.00 (95% CI 0.17 to 5.89; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>) (see <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Multiple organ failure (MOF)</HEADING>
<P>Six studies collected data for this outcome comprising 278 participants (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>; <LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>). The RR was 0.55 (95% CI 0.37 to 0.81; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>) (see <LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>).</P>
<P>Four of those trials included only patients with SAP (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>) and so a subgroup analysis was done that showed a RR of 0.46 (95% CI 0.16 to 1.29; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>) (see <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Operative intervention</HEADING>
<P>This was reported in seven studies with 316 participants (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>; <LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>; <LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>). Operative interventions showed a RR of 0.44 (95% CI 0.29 to 0.67; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>) (see <LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>).</P>
<P>In patients with SAP in four of those trials (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>), the RR was 0.38 (95% CI 0.22 to 0.66; <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>) (see <LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Systemic infection</HEADING>
<P>This outcome was reported in seven trials with a total of 295 participant (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>; <LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK> ), and showed a RR of 0.39 (95% CI 0.23 to 0.65; <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>) (see <LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>).</P>
<P>Among those, the four trials that included only patients with SAP (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>), had a RR of 0.39 (95% CI 0.17 to 0.90; <LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>) (see <LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7. Local septic complications</HEADING>
<P>Five studies assessed this outcome including a total of 246 participants. The RR for local septic complications with EN vs TPN was 0.74 (95% CI 0.40 to 1.35; <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>) (<LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>).</P>
<P>Subgroup analysis of the three trials with SAP (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>), had a RR of 0.93 (95% CI 0.07 to 12.59; <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>) (see <LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8. Other local complications</HEADING>
<P>There were five studies that reported this outcome with a total sample size of 230 (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>). The RR for other local complications with EN vs TPN was 0.70 (95% CI 0.43 to 1.13; <LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>) (<LINK REF="FIG-17" TYPE="FIGURE">Figure 17</LINK>).</P>
<P>Subgroup analysis of two of those trials with SAP (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>), revealed a RR of 0.55 (95% CI 0.20 to 1.50; <LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>) (see <LINK REF="FIG-18" TYPE="FIGURE">Figure 18</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9. Protection of gut mucosal barrier</HEADING>
<P>This was reported in only two studies (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>). They each reported different parameters and there was insufficient data to include them in a meta-analysis so a narrative description was used instead.</P>
<P>In the first study (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>), the authors measured serum levels of tumour necrosis factor alpha (TNF-&#945;) and Interleukine-6 (IL-6) at baseline, day 5 and day 10. This data was provided in graphs without absolute values of means or SD. Furthermore, no details were provided about which statistical measures were used. The author was contacted and provided the missing data, we used that to calculate the change in score from the baseline. Two decimals were taken and rounded to the closest whole number. For TNF-&#945;, the change in means from baseline was 59.3% for the EN group and -1.2% for the TPN group. On the other hand, IL-6 showed 83.6% reduction from the baseline value compared to 58.7% for TPN. The study concluded that there were no significant differences observed between the two groups with a P value &gt;0.05.</P>
<P>In (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>), the study measured plasma glutamine levels, thiobarbituric acid-reactive substances (TBARS), and the concentration of anti-endotoxin antibodies (IgG and IgM) on admission, day 3 and day 7. These values were presented in medians and ranges. From the provided tables, we calculated the median change in score for each outcome. In the EN group, serum glutamine level showed a reduction of 6.3% compared to a 15.9% increase for TPN. For TBARS, there was a 56.7% and 95.6% increase from baseline for the EN and TPN group respectively. Moving on to the plasma anti-endotoxin core antibodies, the EN group had a 44.8% and 21.2% reduction in the IgG and IgM levels respectively, while the TPN group revealed an increase of 28.4% and 38.8% of IgG and IgM levels respectively. The authors concluded that there was no difference in glutamine or TBARS concentrations between the groups at any time. Both IgG and IgM concentrations were raised in all patients on admission. IgG levels tended to fall over the study period in the EN group, while a significant rise was observed in the TPN group from day 3 to day 7 (P = 0.028). IgM antibodies fell significantly in the EN group, while in the TPN group, they had a non-significant rise (P = 0.51).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2009-11-03 22:31:02 +0000" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<SUMMARY_OF_RESULTS MODIFIED="2009-09-16 15:27:18 +0100" MODIFIED_BY="Cathy Bennett">
<P>One of the main concerns in severe acute pancreatitis is the high risk of mortality that is most commonly secondary to systemic infections and multiple organ failure. The findings of this review show significant benefits favouring EN over TPN by decreasing mortality, multiple organ failure, systemic infection, and operative interventions. In addition, there was a trend for a decrease in length of hospital stay, local septic complications and other local complications. All the trials resulted in outcomes that favour the EN group over the TPN group. The quality of the evidence supporting these findings is summarized in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK> showing low quality for mortality and length of hospital stay while all other outcomes were of moderate quality.</P>
<P>We undertook subgroup analysis of trials that included only patients with SAP for all outcomes to see if there would be a change in the magnitude of effect. This included four trials that included only patients with SAP (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-Petrov-2006" TYPE="STUDY">Petrov 2006</LINK>), and one additional trial that included a subgroup analysis for SAP patients for length of hospital stay only (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>). Interestingly, the main outcome that is most likely to affect decision makers; mortality, showed a dramatic reduction from a RR of 0.50 (95% CI 0.28 to 0.91) in all patients with acute pancreatitis to a RR of 0.18 (95% CI 0.06 to 0.58) in patients with SAP in favour of the EN group (see <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). Furthermore, the need for operative interventions similarly showed a reduction in RR for patients with SAP receiving EN (see <LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>), while systemic infections were similar in both groups (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>; <LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>). It was also observed that a trend in further reduction in length of hospital stay, the incidence of MOF, local septic complications and other local complications was evident in the EN group.(<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>; <LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>; <LINK REF="FIG-18" TYPE="FIGURE">Figure 18</LINK>). We find that these results are important and should be taken into consideration when encountering patients with SAP and deciding on the route of supplemental nutrition.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2009-11-03 22:28:59 +0000" MODIFIED_BY="[Empty name]">
<P>All the studies we included involved patients with acute pancreatitis who received either TPN or EN. Endpoints of the studies were similar overall to the intended outcome measures of the review. Severity of pancreatitis varied among studies, with some including only patients with severe acute pancreatitis (SAP), others moderate, and some a combination of both. This should be kept in mind when taking decisions for different patients.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2009-07-16 13:34:05 +0100" MODIFIED_BY="[Empty name]">
<P>Overall, our review included eight randomised controlled trials with a total of 348 participants. Key methodological limitations included inadequate method of allocation concealment in one study (<LINK REF="STD-Olah-2002" TYPE="STUDY">Olah 2002</LINK>); using day of birth for allocation and three others provided insufficient information to judge. However, although two studies were underpowered (<LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK> and <LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>) and the majority of studies included a rather small number of participants, they were consistent in their results in terms of favouring EN over TPN.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2009-11-03 22:30:26 +0000" MODIFIED_BY="[Empty name]">
<P>A number of limitations were encountered in the process of updating this review. The studies included were of small sample size, and two trials were underpowered to detect the desirable outcome (<LINK REF="STD-Louie-2005" TYPE="STUDY">Louie 2005</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>).</P>
<P>A limitation we came across was the common finding of missing statistical measurements such as the standard deviation (SD) for length of hospital stay in <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>; <LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>. The authors were contacted, two replied, all missing data was provided by one (<LINK REF="STD-Casas-2007" TYPE="STUDY">Casas 2007</LINK>), one was unable to provide the missing data (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>), and no response received from the remaining one. In <LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>, the measurements of continuous outcomes were presented in medians and ranges. No other statistical measurement were provided to indicate if the data was skewed or not, furthermore, no other measurement of variance was provided to indirectly calculate the SD. Considering the rather small sample size (N=17) we assumed that it was skewed and did not include it in the meta-analysis. Two studies did not directly provide the SD (<LINK REF="STD-Abou_x002d_Assi-2002" TYPE="STUDY">Abou-Assi 2002</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK> ) so it was calculated from the standard error (SE), and in one (<LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>), it was imputed by calculating the average of the other three studies.</P>
<P>None of studies addressed any conflict of interest. In two studies (<LINK REF="STD-Gupta-2003" TYPE="STUDY">Gupta 2003</LINK>; <LINK REF="STD-McClave-1997" TYPE="STUDY">McClave 1997</LINK>), the extent of involvement of their funding provider was not addressed. This might have been helpful considering that their product was used in the intervention group and their study revealed a positive result.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2009-11-03 22:31:02 +0000" MODIFIED_BY="[Empty name]">
<P>A couple of meta-analyses have addressed the issue of route of nutrition in acute pancreatitis and its effect on a number of important outcomes. Marik and Zaloga (<LINK REF="REF-Marik-2004" TYPE="REFERENCE">Marik 2004</LINK>) included six trials with 263 participants and found significant reduction in infections, surgical interventions and length of hospital stay in the EN group compared to the TPN group. A reduction in mortality was also observed but was not statistically significant. Similarly, McClave and colleagues included seven trials with a total of 291 patients and found that the EN group had significant reduction in length of hospital stay and infectious morbidity compared to the TPN group (<LINK REF="REF-McClave-2006" TYPE="REFERENCE">McClave 2006</LINK>).The reduction in mortality was once again found to be insignificant. Both meta-analyses concluded that EN should be the preferred route in patients with severe acute pancreatitis.</P>
<P>We disagree with <LINK REF="REF-McClave-2006" TYPE="REFERENCE">McClave 2006</LINK> in the fact that the conclusions did not put into consideration the validity of the results described. On the other hand, <LINK REF="REF-Marik-2004" TYPE="REFERENCE">Marik 2004</LINK> utilized a scale for assessment of risk of bias by Jadad and colleagues (<LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>) that is an unreliable tool for assessment of validity suffering from the generic problems of scales (<LINK REF="REF-J_x00fc_ni-1999" TYPE="REFERENCE">Jni 1999</LINK>).</P>
<P>Our review is in agreement with the above mentioned meta-analyses in that the group receiving EN had less morbidity and mortality. Furthermore, it gives an updated and comprehensive overview of the topic at hand with results based on the risk of bias for each outcome by reliable tools that allow transparent and detailed report of factors affecting validity (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-11-03 22:31:22 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2009-11-03 22:31:22 +0000" MODIFIED_BY="[Empty name]">
<P>The findings of this review support the use of EN in patients with acute pancreatitis requiring nutritional support over TPN. Patients receiving EN are less likely to suffer form MOF, systemic infections, operative interventions and, more importantly, death. The quality of evidence for these outcomes are of moderate quality (as shown in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>) except for death being of low quality. The best available evidence is in favour of EN.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-07-03 11:21:22 +0100" MODIFIED_BY="[Empty name]">
<P>The current evidence suggests that enteral nutrition via a nasojejunal tube is superior to TPN in patients with acute pancreatitis. Nasojejunal tubes have their own difficulties in insertion, dislodgement and blockage. A number of trials have proposed yet an easier and cheaper method for nutrition; enteral nutrition to the stomach rather than to the jejunum and have shown its safety and effectiveness (<LINK REF="REF-Eatock-2005" TYPE="REFERENCE">Eatock 2005</LINK>; <LINK REF="REF-Kumar-2006" TYPE="REFERENCE">Kumar 2006</LINK>). Further well conducted randomized controlled trials comparing enteral nutrition via nasogastric tubes to nasojejunal tubes in patients with severe acute pancreatitis with adequately calculated sample sizes to test for equivalence are required before proposing this method of treatment in such patients. Outcomes that are necessary to address include mortality, multiple organ failure, systemic infections, length of hospital stay, the need for operative interventions, local septic complications, and SIRS.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2009-09-23 13:00:33 +0100" MODIFIED_BY="Cathy Bennett">
<P>We would like to acknowledge the major contributions of Dr Ala Groof and Dr Derek Wilke for previous versions of this review, they would like to extend their thanks to Dr Arne Ohlsson for his efforts in teaching them how to conduct a systemic review during the Cochrane Reviews course at University of Toronto. We would like to thank those whom assisted us in hunting down the full articles for a number of studies; Racquel Simpson and Dr Ayman Abdo. For statistical support and guidance, we would like to thank Dr Shaffi from King Saud University.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-06-27 17:47:35 +0100" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-09-16 15:31:09 +0100" MODIFIED_BY="Cathy Bennett">
<P>Mohammed Al-Omran: Concept and design of the review, protocol development, and final approval of the manuscript to be submitted for publication.</P>
<P>Zaina AlBalawi: Selection of studies, quality assessment, data extraction, data analysis, update of the review.</P>
<P>Mariam Tashkandi: Selection of studies, quality assessment, data extraction, data analysis, update of the review.</P>
<P>Lubna Al-Ansary: Critical revision for intellectual content, and final approval of the manuscript to be submitted for publication.</P>
<P>Ala Groof and Derek Wilke contributed to the development of the protocol and first published version of the review. They both took part in screening the studies for relevance, extracting data and assessment of quality of studies of the original review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2009-11-04 11:25:06 +0000" MODIFIED_BY="Jan Lilleyman">
<SUBSECTION>
<HEADING LEVEL="2">Methods</HEADING>
<P>For the inclusion criteria we found it reasonable to include studies that inserted nasojejunal tubes blindly as long as they were confirmed by an X-ray or other radiological methods since it complied with our objective of ensuring that the tube was positioned in the jejunum. Another addition was in the search strategy where the old RCT filters were replaced by the new ones described in <LINK REF="REF-Lefebvre-2008" TYPE="REFERENCE">Lefebvre 2008</LINK> because they have been found to be more sensitive. Another addition was the inclusion of searching for ongoing trials through <A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>. In addition, we replaced the old tool for assessment of risk of bias with the tool described in <LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK> as it provides a more transparent and detailed assessment of validity of included studies. We planned on assessing for publication and reporting bias if ten or more studies were included in any outcome (<LINK REF="REF-Sterne-2008" TYPE="REFERENCE">Sterne 2008</LINK>) as it is considered to be a threat for validity. In the outcomes section, we added line sepsis under systemic infections as it is recognized as an important source of infection that may affect morbidity and mortality. Instead of applying a random-effects model for all outcomes, we made the decision based on the significance of heterogeneity: where studies were found to be significant for heterogeneity indicated by a P value &lt; 0.1, a random-effects model would be applied, while if they were homogenous, a fixed-effects model would be applied. Finally, a 'Summary of findings' table was included in accordance with the recommendation of the Cochrane Handbook for Systematic Reviews of Interventions to provide a transparent and simple tabular format of the review&#8217;s main outcomes that are likely to be of importance to patients and decision makers (<LINK REF="REF-Sch_x00fc_nemann-2008" TYPE="REFERENCE">Schnemann 2008</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Authorship</HEADING>
<P>Three new authors joined the group and were involved in the development and update of this review; (Al-Ansary LA, Tashkandi MF and AlBalawi ZH). The first author remains unchanged; however, two previous authors whom contributed to development of the original review were unable to take part in the update or approval of this review and were therefore acknowledged for their efforts and previous contributions.</P>
</SUBSECTION>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-09-16 16:08:23 +0100" MODIFIED_BY="Cathy Bennett">
<STUDIES MODIFIED="2009-09-16 15:49:33 +0100" MODIFIED_BY="Cathy Bennett">
<INCLUDED_STUDIES MODIFIED="2009-09-16 15:46:35 +0100" MODIFIED_BY="Cathy Bennett">
<STUDY DATA_SOURCE="PUB" ID="STD-Abou_x002d_Assi-2002" MODIFIED="2009-09-16 15:38:35 +0100" MODIFIED_BY="Cathy Bennett" NAME="Abou-Assi 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-09-16 15:38:35 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abou-Assi S, Craig K, O&#8217;Keefe SJD</AU>
<TI>Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: Results of a randomized comparative study</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2002</YR>
<VL>97</VL>
<PG>2255-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Casas-2007" MODIFIED="2009-09-16 15:40:01 +0100" MODIFIED_BY="Cathy Bennett" NAME="Casas 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-09-16 15:40:01 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Casas M, Mora J, Fort E, Aracil C, Busquets D, Galter S, Juregui CE, Ayala E, Cardona D, Gich I, Farr A</AU>
<TI>Total enteral nutrition v.s total parenteral nutrition in patients with severe acute pancreatitis</TI>
<SO>Revista Espaola de Enfermedades Digestivas</SO>
<YR>2007</YR>
<VL>99</VL>
<NO>5</NO>
<PG>264-269</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-2003" MODIFIED="2009-07-03 18:48:26 +0100" MODIFIED_BY="[Empty name]" NAME="Gupta 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-07-03 18:48:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gupta R, Patel K, Calder PC, Yaqoob P, Primrose JN, Johnson CD</AU>
<TI>A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II &#8805;6)</TI>
<SO>Pancreatology</SO>
<YR>2003</YR>
<VL>3</VL>
<PG>406-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kalfarentzos-1997" MODIFIED="2009-09-16 15:40:28 +0100" MODIFIED_BY="Cathy Bennett" NAME="Kalfarentzos 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-09-16 15:40:28 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA</AU>
<TI>Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial</TI>
<SO>British Journal of Surgery</SO>
<YR>1997</YR>
<VL>84</VL>
<PG>1665-1669</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Louie-2005" MODIFIED="2009-09-16 15:40:48 +0100" MODIFIED_BY="Cathy Bennett" NAME="Louie 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-09-16 15:40:48 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Louie BE, Noseworthy T, Hailey D, Gramlich LM, Jacobs P, Warnock GL</AU>
<TI>2004 MacLean&#8211;Mueller Prize enteral or parenteral nutrition for severe pancreatitis: A randomized controlled trial and health technology assessment</TI>
<SO>Canadian Journal of Surgery</SO>
<YR>2005</YR>
<VL>48</VL>
<PG>298-306</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McClave-1997" MODIFIED="2009-09-16 15:46:35 +0100" MODIFIED_BY="Cathy Bennett" NAME="McClave 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-09-16 15:46:35 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McClave SA, Greene LM, Snider HL, Mark LJK, Cheadle WG, Owens NA, Dukes LG, Goldsmith LJ</AU>
<TI>Comparison of the safety of early enteral versus parenteral nutrition in mild acute pancreatitis</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1997</YR>
<VL>21</VL>
<PG>14-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olah-2002" MODIFIED="2009-07-03 18:48:51 +0100" MODIFIED_BY="[Empty name]" NAME="Olah 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-07-03 18:48:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olah A, Pardavi G, Belagyi T, Nagy A, Issekutz A, Mohamed GE</AU>
<TI>Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate</TI>
<SO>Nutrition</SO>
<YR>2002</YR>
<VL>18</VL>
<PG>259-262</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petrov-2006" MODIFIED="2009-09-16 15:41:43 +0100" MODIFIED_BY="Cathy Bennett" NAME="Petrov 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-09-16 15:41:43 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petrov MS, Kukosh MV, Emelyanov NV</AU>
<TI>A Randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition</TI>
<SO>Digestive Surgery</SO>
<YR>2006</YR>
<VL>23</VL>
<PG>336-345</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-09-16 15:49:33 +0100" MODIFIED_BY="Cathy Bennett">
<STUDY DATA_SOURCE="PUB" ID="STD-Bao-2006" MODIFIED="2009-07-16 13:49:03 +0100" MODIFIED_BY="[Empty name]" NAME="Bao 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-16 13:49:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bao J, Jing D, Wang P, Wang X</AU>
<TI>Effects of early jejunum nutrition on the comprehensive therapy for severe acute pancreatitis</TI>
<SO>Chinese Journal of Gastroenterology</SO>
<YR>2006</YR>
<VL>11</VL>
<NO>5</NO>
<PG>259-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eckerwall-2006" MODIFIED="2009-07-03 16:02:28 +0100" MODIFIED_BY="[Empty name]" NAME="Eckerwall 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-03 16:02:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eckerwall GE, Axelsson JB, Andersson RG</AU>
<TI>Early nasogastric feeding in predicted severe acute pancreatitis a clinical, randomized study</TI>
<SO>Annals of Surgery</SO>
<YR>December 2006</YR>
<VL>244</VL>
<PG>959-965</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hernandez_x002d_Aranda1996" NAME="Hernandez-Aranda1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herandez-Aranda JC, Gallo-Chio B, Ramirez-Barba EJ</AU>
<TI>Nutritional support in severe acute pancreatitis. Controlled clinical trial</TI>
<TO>Apoyo nuttricional en pancreatitis aguda grave. Ensayo clinico controlado</TO>
<SO>Nutricion Hospitalaria</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>160-166</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Modena-2006" MODIFIED="2009-07-16 14:02:57 +0100" MODIFIED_BY="[Empty name]" NAME="Modena 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-16 14:02:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Modena JT, Cevasco LB, Basot CA, Vicuna AO, Ramirez MP</AU>
<TI>Total enteral nutrition as prophylactic therapy for pancreatic necrosis infection in severe acute pancreatitis</TI>
<SO>Pancreatology</SO>
<YR>2006</YR>
<VL>6</VL>
<PG>58-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powell-2000" MODIFIED="2009-09-16 15:46:04 +0100" MODIFIED_BY="Cathy Bennett" NAME="Powell 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-09-16 15:46:04 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powell JJ, Murchison JT, Fearon KCH, Ros JA, Siriwardena AK</AU>
<TI>Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis</TI>
<SO>British Journal of Surgery</SO>
<YR>2000</YR>
<VL>87</VL>
<PG>1375-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Windsor-1996" MODIFIED="2009-09-16 15:49:33 +0100" MODIFIED_BY="Cathy Bennett" NAME="Windsor 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-09-16 15:49:33 +0100" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Windsor ACJ, Li A, Guthrie A, Barnes E, Somers SS, Welsh F, Guillou PJ, Reynolds JV</AU>
<TI>Feeding the gut in acute pancreatitis: a randomized clinical trial of enteral versus parenteral nutrition</TI>
<SO>British Journal of Surgery</SO>
<YR>1996</YR>
<VL>83</VL>
<PG>689</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Windsor-1998" NAME="Windsor 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Windsor ACJ, Kanwar S, Li AGK, Barnes E, Guthrie JA, Spark JI, Welsh F, Guillou PJ, Reynolds JV</AU>
<TI>Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis</TI>
<SO>Gut</SO>
<YR>1998</YR>
<VL>42</VL>
<PG>431-435</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ye-2007" MODIFIED="2009-07-03 18:51:32 +0100" MODIFIED_BY="[Empty name]" NAME="Ye 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-07-03 18:51:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ye P, Wu W, Liu J, Xu K</AU>
<TI>Early enteral nutrition in the treatment of acute pancreatitis</TI>
<SO>Chinese Journal of Gastroenterology</SO>
<YR>2007</YR>
<VL>12</VL>
<NO>7</NO>
<PG>411-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-07-16 13:49:03 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-09-16 16:08:23 +0100" MODIFIED_BY="Cathy Bennett">
<ADDITIONAL_REFERENCES MODIFIED="2009-09-16 16:08:23 +0100" MODIFIED_BY="Cathy Bennett">
<REFERENCE ID="REF-Alexender-1980" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Alexender 1980" TYPE="JOURNAL_ARTICLE">
<AU>Alexender JW, MacMillan BG, Stinnert JD</AU>
<TI>Beneficial effects of aggressive protein feeding in severely burned children</TI>
<SO>Surgery</SO>
<YR>1980</YR>
<VL>192</VL>
<PG>505-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ammori-1999" MODIFIED="2009-09-16 15:46:03 +0100" MODIFIED_BY="Cathy Bennett" NAME="Ammori 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ammori BJ, Leeder PC, King RF, Barclay GR, Martin IG, Larvin M, McMahon MJ</AU>
<TI>Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>1999</YR>
<VL>3</VL>
<PG>252-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Balthazar-1990" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Balthazar 1990" TYPE="JOURNAL_ARTICLE">
<AU>Balthazar EJ, Robinson DL, Megibow AJ, Ranson JHC</AU>
<TI>Acute pancreatitis: value of CT scan in establishing prognosis</TI>
<SO>Radiology</SO>
<YR>1990</YR>
<VL>174</VL>
<PG>331-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Banks-2006" MODIFIED="2009-09-16 15:46:03 +0100" MODIFIED_BY="Cathy Bennett" NAME="Banks 2006" TYPE="JOURNAL_ARTICLE">
<AU>Banks PA, Freeman ML, and the Practice Parameters Committee of the American College of Gastroenterology</AU>
<TI>Practice Guidelines in Acute Pancreatitis</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2006</YR>
<VL>101</VL>
<PG>2379-2400</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blamey-1984" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Blamey 1984" TYPE="JOURNAL_ARTICLE">
<AU>Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC</AU>
<TI>Prognostic factors in acute pancreatitis</TI>
<SO>Gut</SO>
<YR>1984</YR>
<VL>25</VL>
<PG>1304-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bradley-1993" MODIFIED="2008-10-30 11:31:37 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Bradley 1993" TYPE="JOURNAL_ARTICLE">
<AU>Bradley EL III</AU>
<TI>A clinically based classification system for acute pancreatitis. Summary of the International Symposium of Acute Pancreatitis, Atlanta, Ga, September 11-13</TI>
<SO>Arch Surg</SO>
<YR>1993</YR>
<VL>128</VL>
<PG>586-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-British-Society-of-Gastroenterology-2005" MODIFIED="2009-07-02 12:51:49 +0100" MODIFIED_BY="[Empty name]" NAME="British Society of Gastroenterology 2005" TYPE="JOURNAL_ARTICLE">
<AU>British Society of Gastroenterology</AU>
<TI>United Kingdom guidelines for the management of acute pancreatitis</TI>
<SO>Gut</SO>
<YR>2005</YR>
<VL>54</VL>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buchman-1995" MODIFIED="2009-09-16 15:50:36 +0100" MODIFIED_BY="Cathy Bennett" NAME="Buchman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Buchman AL, Moukarazel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD, Vijayaroghavan SR</AU>
<TI>Parenteral nutrition is associated with intestinal morphologic and functional changes in humans</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1995</YR>
<VL>19</VL>
<PG>453-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Corcoy-1988" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Corcoy 1988" TYPE="JOURNAL_ARTICLE">
<AU>Corcoy R, Ma Sanachez J, Domingo P, et al</AU>
<TI>Nutrition in patients with severe acute pancreatitis</TI>
<SO>Nutrition</SO>
<YR>1988</YR>
<VL>4</VL>
<PG>269-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eatock-2005" MODIFIED="2009-09-16 15:51:18 +0100" MODIFIED_BY="Cathy Bennett" NAME="Eatock 2005" TYPE="JOURNAL_ARTICLE">
<AU>Eatock FC, Chong P, Menezes N, Murray L, McKay CJ, Carter CR, Imrie CW</AU>
<TI>A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2005</YR>
<VL>100</VL>
<NO>2</NO>
<PG>432-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fink-1991" MODIFIED="2009-09-16 15:51:38 +0100" MODIFIED_BY="Cathy Bennett" NAME="Fink 1991" TYPE="JOURNAL_ARTICLE">
<AU>Fink MP</AU>
<TI>Gastrointestinal mucosal injury in experimental models of shock, trauma and sepsis</TI>
<SO>Critical Care Medicine</SO>
<YR>1991</YR>
<VL>19</VL>
<PG>627-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gardiner-1995" MODIFIED="2009-09-16 15:52:24 +0100" MODIFIED_BY="Cathy Bennett" NAME="Gardiner 1995" TYPE="JOURNAL_ARTICLE">
<AU>Gardiner KR, Kirk SJ, Rowlands BD</AU>
<TI>Novel substrates to maintain gut integrity</TI>
<SO>Nutrition Research Reviews</SO>
<YR>1995</YR>
<VL>8</VL>
<PG>43-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goodgame-1977" MODIFIED="2009-09-16 15:52:44 +0100" MODIFIED_BY="Cathy Bennett" NAME="Goodgame 1977" TYPE="JOURNAL_ARTICLE">
<AU>Goodgame JT, Fischer JE</AU>
<TI>Parenteral nutrition in the treatment of pancreatitis: effect on complications and mortality</TI>
<SO>Annals of Surgery</SO>
<YR>1977</YR>
<VL>186</VL>
<PG>651-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grant-1984" MODIFIED="2009-09-16 15:52:59 +0100" MODIFIED_BY="Cathy Bennett" NAME="Grant 1984" TYPE="JOURNAL_ARTICLE">
<AU>Grant JP, James S, Gratosowski V, Trexler KM</AU>
<TI>Total parenteral nutrition in pancreatic disease</TI>
<SO>Annals of Surgery</SO>
<YR>1984</YR>
<VL>200</VL>
<PG>627-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hancke-1987" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Hancke 1987" TYPE="BOOK_SECTION">
<AU>Hancke E, Marlein G</AU>
<TI>Bacterial contamination of the pancreas with intestinal germs: A cause of acute suppurative pancreatitis</TI>
<SO>Acute Pancreatitis</SO>
<YR>1987</YR>
<PG>87-9</PG>
<ED>Berger HG</ED>
<PB>Spring-Verlag</PB>
<CY>Berlin</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Havala-1989" MODIFIED="2009-09-16 15:53:25 +0100" MODIFIED_BY="Cathy Bennett" NAME="Havala 1989" TYPE="JOURNAL_ARTICLE">
<AU>Havala T, Shronts E, Cerra F</AU>
<TI>Nutritinal support in acute pancreatitis</TI>
<SO>Gastroenterology Clinics of North America</SO>
<YR>1989</YR>
<VL>18</VL>
<PG>525-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Helton-1990" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Helton 1990" TYPE="BOOK_SECTION">
<AU>Helton WS</AU>
<TI>Intravenous nutrition in patients with acute pancreatitis</TI>
<SO>Clinical nutrition: Parenteral nutrition</SO>
<YR>1990</YR>
<PG>442-61</PG>
<ED>Rombeau JL</ED>
<PB>WB Saunders</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-07-03 14:28:50 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Altman DG (editors)</AU>
<SO>Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Greens S (editors). Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PB>John Wiley &amp; sons</PB>
<CY>Chichester (UK)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008a" MODIFIED="2009-07-03 14:29:28 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008a" TYPE="BOOK">
<AU>Higgins JPT, Deeks JJ, Altman DG (editors)</AU>
<SO>Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PB>John Wiley &amp; Sons</PB>
<CY>Chichester (UK)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" MODIFIED="2009-07-01 08:26:53 +0100" MODIFIED_BY="[Empty name]" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay H</AU>
<TI>Assessing the quality of reports of randomized clinical trials: Is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-J_x00fc_ni-1999" MODIFIED="2009-07-01 08:30:38 +0100" MODIFIED_BY="[Empty name]" NAME="Jni 1999" TYPE="JOURNAL_ARTICLE">
<AU>Jni P, Witschi A, Bloch R, Egger M</AU>
<TI>The hazards of scoring the quality of clinical trials for meta-analysis</TI>
<SO>JAMA</SO>
<YR>1999</YR>
<VL>282</VL>
<PG>1054-1060</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kalfarentzos-1991" MODIFIED="2009-09-16 15:54:49 +0100" MODIFIED_BY="Cathy Bennett" NAME="Kalfarentzos 1991" TYPE="JOURNAL_ARTICLE">
<AU>Kalfarentzos FE, Karavias DD, Karatzas TM Alevizatos BA, Androulakis JA</AU>
<TI>Total parenteral nutrition in severe acute pancreatitis</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1991</YR>
<VL>10</VL>
<PG>156-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keys-1950" MODIFIED="2008-10-30 11:31:37 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Keys 1950" TYPE="BOOK">
<AU>Keys A, Brozek J, Henschel A</AU>
<SO>The biology of human starvation</SO>
<YR>1950</YR>
<PB>University of Minnesota Press</PB>
<CY>Minneapolis</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Knaus-1985" MODIFIED="2009-09-16 15:55:10 +0100" MODIFIED_BY="Cathy Bennett" NAME="Knaus 1985" TYPE="JOURNAL_ARTICLE">
<AU>Knaus WA, Draper EA, Wagner DP, Zimmerman JE</AU>
<TI>APACHE-II: a severity of disease classification</TI>
<SO>Critical Care Medicine</SO>
<YR>1985</YR>
<VL>13</VL>
<PG>818-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Knaus-1991" MODIFIED="2009-07-03 15:13:39 +0100" MODIFIED_BY="[Empty name]" NAME="Knaus 1991" TYPE="JOURNAL_ARTICLE">
<AU>Knaus WA, Wagner DP, Draper EA, et al</AU>
<TI>The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized patients</TI>
<SO>Chest</SO>
<YR>1991</YR>
<VL>100</VL>
<PG>1619-1636</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kumar-2006" MODIFIED="2009-09-16 15:55:39 +0100" MODIFIED_BY="Cathy Bennett" NAME="Kumar 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kumar A, Singh N, Prakash S, Saraya A, Joshi YK</AU>
<TI>Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes</TI>
<SO>Journal of Clinical Gastroenterology</SO>
<YR>2006</YR>
<VL>40</VL>
<NO>5</NO>
<PG>431-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lange-1987" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Lange 1987" TYPE="JOURNAL_ARTICLE">
<AU>Lange JF, van Gool J, Tytgat GN</AU>
<TI>The protective effect of a reduction in intestinal flora on mortality of acute haemorrhagic pancreatitis in the rat</TI>
<SO>Hepatogastroenterology</SO>
<YR>1987</YR>
<VL>34</VL>
<PG>28-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2008" MODIFIED="2009-06-30 10:43:15 +0100" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2008" TYPE="BOOK">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<SO>Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PB>Wiley</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marik-2004" MODIFIED="2009-06-30 23:38:12 +0100" MODIFIED_BY="[Empty name]" NAME="Marik 2004" TYPE="JOURNAL_ARTICLE">
<AU>Marik PE, Zaloga GP</AU>
<TI>Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis</TI>
<SO>BMJ</SO>
<YR>2004</YR>
<VL>328</VL>
<PG>1407</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maxton-1989" MODIFIED="2009-09-16 16:01:23 +0100" MODIFIED_BY="Cathy Bennett" NAME="Maxton 1989" TYPE="JOURNAL_ARTICLE">
<AU>Maxton DG, Menzies IS, Salvin B, Thompson RPH</AU>
<TI>Small intestinal function during enteral feeding and starvation in man</TI>
<SO>Clinical Science (Colch.)</SO>
<YR>1989</YR>
<VL>77</VL>
<PG>401-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McClave-1986" MODIFIED="2009-09-16 16:01:49 +0100" MODIFIED_BY="Cathy Bennett" NAME="McClave 1986" TYPE="JOURNAL_ARTICLE">
<AU>McClave EE, Jones TN</AU>
<TI>Benefits of immediate jejunostomy feeding after major abdominal trauma - a prospective randomized trial</TI>
<SO>Journal of Trauma</SO>
<YR>1986</YR>
<VL>26</VL>
<PG>874-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McClave-1998" MODIFIED="2009-09-16 16:02:11 +0100" MODIFIED_BY="Cathy Bennett" NAME="McClave 1998" TYPE="JOURNAL_ARTICLE">
<AU>McClave SA, Snider H, Owens N, Sexton LK</AU>
<TI>Nutritional management in acute and chronic pancreatitis</TI>
<SO>Gastroenterology Clinics of North America</SO>
<YR>1998</YR>
<VL>27</VL>
<PG>421-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McClave-2006" MODIFIED="2009-09-16 16:03:44 +0100" MODIFIED_BY="Cathy Bennett" NAME="McClave 2006" TYPE="JOURNAL_ARTICLE">
<AU>McClave SA, Chang WK, Dhaliwal R, Heyland DK</AU>
<TI>Nutrition support in acute pancreatitis: a systematic review of the literature</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>2006</YR>
<VL>30</VL>
<NO>2</NO>
<PG>143-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moore-1992" MODIFIED="2009-09-16 16:04:03 +0100" MODIFIED_BY="Cathy Bennett" NAME="Moore 1992" TYPE="JOURNAL_ARTICLE">
<AU>Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB, Kellum JM Jr, Welling RE, Moore EE</AU>
<TI>Early enteral compared with parenteral nutrition reduces postoperative septic complications: the results of a meta-analysis</TI>
<SO>Annals of Surgery</SO>
<YR>1992</YR>
<VL>216</VL>
<PG>172-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pisters-1992" MODIFIED="2009-09-16 16:05:07 +0100" MODIFIED_BY="Cathy Bennett" NAME="Pisters 1992" TYPE="JOURNAL_ARTICLE">
<AU>Pisters PW, Ranson JHC</AU>
<TI>Nutritional support of acute pancreatitis</TI>
<SO>Surgery Gynecology &amp; Obstetrics</SO>
<YR>1992</YR>
<VL>175</VL>
<PG>275-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Povoski-1995" MODIFIED="2009-09-16 16:05:25 +0100" MODIFIED_BY="Cathy Bennett" NAME="Povoski 1995" TYPE="JOURNAL_ARTICLE">
<AU>Povoski SP, Nussbaum MS</AU>
<TI>Nutrition support in pancreatitis: fertile ground for prospective clinical investigation</TI>
<SO>Nutrition in Clinical Practice</SO>
<YR>1995</YR>
<VL>10</VL>
<PG>43-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Runkel-1991" MODIFIED="2009-09-16 16:05:49 +0100" MODIFIED_BY="Cathy Bennett" NAME="Runkel 1991" TYPE="JOURNAL_ARTICLE">
<AU>Runkel NS, Moody FG, Smith GS, Rodriguez MT, LaRocco MT, Miller TA</AU>
<TI>The role of the gut in the development of sepsis in acute pancreatitis</TI>
<SO>Journal of Surgical Research</SO>
<YR>1991</YR>
<VL>51</VL>
<PG>18-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Russel-1983" MODIFIED="2009-09-16 16:06:12 +0100" MODIFIED_BY="Cathy Bennett" NAME="Russel 1983" TYPE="JOURNAL_ARTICLE">
<AU>Russel JC, Welch JP, Clark DG</AU>
<TI>Colonic complications of acute pancreatitis and pancreatic abscess</TI>
<SO>American Journal of Surgery</SO>
<YR>1983</YR>
<VL>146</VL>
<PG>558-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ryan-1993" MODIFIED="2008-10-30 11:31:38 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Ryan 1993" TYPE="JOURNAL_ARTICLE">
<AU>Ryan CM, Schmidt J, Lawandrowski K, Compton CC, Rattner DW, Warshaw AL, Tompkins RG</AU>
<TI>Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats</TI>
<SO>Gastroenterology</SO>
<YR>1993</YR>
<VL>104</VL>
<PG>890-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Saadia-1990" MODIFIED="2009-09-16 16:06:31 +0100" MODIFIED_BY="Cathy Bennett" NAME="Saadia 1990" TYPE="JOURNAL_ARTICLE">
<AU>Saadia R, Schein M, MacFarlance C, Boffard KD</AU>
<TI>Gut barrier function and the surgeon</TI>
<SO>British Journal of Surgery</SO>
<YR>1990</YR>
<VL>77</VL>
<PG>487-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2008" MODIFIED="2009-07-01 08:38:08 +0100" MODIFIED_BY="[Empty name]" NAME="Schnemann 2008" TYPE="BOOK_SECTION">
<AU>Schnemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH</AU>
<TI>Chapter 11: Presenting results and Summary of findings tables. In: Higgins JPT, Green S (editors)</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PB>John Wiley &amp; Sons</PB>
<CY>Chichester (UK)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scolapio-1999" MODIFIED="2009-09-16 16:06:49 +0100" MODIFIED_BY="Cathy Bennett" NAME="Scolapio 1999" TYPE="JOURNAL_ARTICLE">
<AU>Scolapio JS, Malhi-Chowla N, Ukleja A</AU>
<TI>Nutrition supplementation in patients with acute and chronic pancreatitis</TI>
<SO>Gastroenterology Clinics of North America</SO>
<YR>1999</YR>
<VL>28</VL>
<PG>695-707</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sitzmann-1989" MODIFIED="2009-09-16 16:07:25 +0100" MODIFIED_BY="Cathy Bennett" NAME="Sitzmann 1989" TYPE="JOURNAL_ARTICLE">
<AU>Sitzmann JV, Steinborn PA, Zinner MJ, Cameron JL</AU>
<TI>Total parenteral nutrition and alternate energy substrates in treatment of severe acute pancreatitis</TI>
<SO>Surgery Gynaecology &amp; Obstetrics</SO>
<YR>1989</YR>
<VL>168</VL>
<PG>311-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Steinberg-1994" MODIFIED="2009-09-16 16:07:46 +0100" MODIFIED_BY="Cathy Bennett" NAME="Steinberg 1994" TYPE="JOURNAL_ARTICLE">
<AU>Steinberg W, Tenner S</AU>
<TI>Acute pancreatitis</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>330</VL>
<PG>1198-210</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sterne-2008" MODIFIED="2009-06-30 10:41:04 +0100" MODIFIED_BY="[Empty name]" NAME="Sterne 2008" TYPE="BOOK">
<AU>Sterne JAC, Egger M, Moher D (editors)</AU>
<SO>Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<PB>John Wiley &amp; Sons</PB>
<CY>Chichester (UK)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Twomey-1985" MODIFIED="2009-09-16 16:08:08 +0100" MODIFIED_BY="Cathy Bennett" NAME="Twomey 1985" TYPE="JOURNAL_ARTICLE">
<AU>Twomey P, Patching S</AU>
<TI>Cost-effectiveness of nutritional support</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1985</YR>
<VL>9</VL>
<PG>3-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-VanGossum-1988" MODIFIED="2009-09-16 16:08:23 +0100" MODIFIED_BY="Cathy Bennett" NAME="VanGossum 1988" TYPE="JOURNAL_ARTICLE">
<AU>VanGossum A, Lemoyne M, Greig PD, Jeejeebhoy KN</AU>
<TI>Lipid associated total parenteral nutrition in patients with severe acute pancreatitis</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1988</YR>
<VL>12</VL>
<PG>250-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-09-23 13:05:41 +0100" MODIFIED_BY="Cathy Bennett">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-09-23 13:05:41 +0100" MODIFIED_BY="Cathy Bennett" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-08-02 03:53:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abou_x002d_Assi-2002">
<CHAR_METHODS MODIFIED="2009-06-30 18:45:38 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized Controlled Trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-08-02 03:53:11 +0100" MODIFIED_BY="[Empty name]">
<P>Number randomised: 53, intervention group 26, control group 27.</P>
<P>Setting: Hospital (ICU and floor).</P>
<P>Age: 46 (range 21-91) years, mean intervention group 48(3), mean control group 50(3).</P>
<P>Sex: Intervention; 16 males and 10 females, control group; 13 males and 14 females.</P>
<P>Study period: January-December 2000.</P>
<P>Hospital Stay (days): Intervention group 12.2(1.9), control group 18.4(1.9).</P>
<P>Diagnostic Criteria:</P>
<P>For Acute Pancreatitis: Acute abdominal pain and 3-fold elevation of serum pancreatic enzymes, amylase, and lipase, with a primary diagnosis of acute pancreatitis.</P>
<P>For Severity:<B> </B>Patients who failed to show improvement were graded by Ransons criteria. Intervention group: Ranson's score: 3.1 (0.5), Control group: Ranson's score: 2.5(0.4).</P>
<P>Inclusion criteria: All patients admitted with acute pancreatitis.</P>
<P>Exclusion criteria: Not requiring nutritional support.</P>
<P>Etiology: Not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-30 18:49:38 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: Jejunal tubes ("Silk," Corpak, Wheeling, IL; "Stay-Put," Novartis, St. Louis Park, MN; or "Dobhoff," Kendall HealthCare, Mansfield, MA) were placed by fluoroscopy or endoscopy. Tube feeding was commenced at 20 ml/h and increased progressively to goal rates over 48h.</P>
<P>Control group: TPN was delivered via central vein catheters in patients in the ICUs and by peripheral catheter in floor patients, electrolytes were first corrected before full nutritional infusions were given.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-06-25 18:40:21 +0100" MODIFIED_BY="[Empty name]">
<P>Duration of hospitalizations</P>
<P>Duration of interventional (EN or TPN) feeding. This also provided a measure of the rate of resolution of disease, the incidence of nutrition-associated complications (i.e., hyperglycemia needing insulin for control and catheter-related sepsis and septicemia)</P>
<P>Tolerance to recommencement of oral feeding</P>
<P>Cost effectiveness analysis</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-30 18:52:04 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: This work was supported in part by a Clinical Research Award from the American College of Gastroenterology and the Medical College of Virginia Hospitals</P>
<P>Conflict of interest: Not stated</P>
<P>Calculated sample size: Yes, it was calculated that they would have more than 80% power to reveal significant differences in nutritional outcome, complications, and costs if 50 patients were randomised.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-23 17:31:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Casas-2007">
<CHAR_METHODS MODIFIED="2009-06-25 18:40:21 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized Controlled Trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-23 17:31:19 +0100" MODIFIED_BY="[Empty name]">
<P>Number randomised: 22; Intervention group 11, control group 11</P>
<P>Setting: Hospital ICU in Barcelona</P>
<P>Age: &gt;17 years, mean age intervention 61.2(+/- 16.6), mean age control 55.6 (+/-15.6)</P>
<P>Sex: Intervention group 8 males and 3 females, control group 8 males and 3 females</P>
<P>Study period: Not stated</P>
<P>Diagnostic criteria:</P>
<P>Acute Pancreatitis: Abdominal pain and increased serum amylase and/or lipase levels at least 3 times the upper limit of the reference range.</P>
<P>Severe Acute Pancreatitis: The diagnosis of SAP was made within 48 hours when two or more of the following criteria were evident:</P>
<P>Acute Physiology and Chronic Health Evaluation (APACHE II) score &#8805;8, C-reactive protein (CRP) level in excess of 150 mg/L, and/or a Balthazar D or E grade in the abdominal CT scan.</P>
<P>Inclusion criteria: Patients of either sex who were 18 years or older with a SAP diagnosis of any etiology. </P>
<P>Exclusion criteria: Under 18 years of age, pregnant women and relapsing chronic pancreatitis cases were excluded.</P>
<P>Etiology: Intervention group; Biliary: 4, Alcohol: 1, Unkown: 3, Other: 3, Control group; Biliary: 7, Alcohol: 4</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-30 18:59:27 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: TEN (PEPTISORB, Nutricia S.R.L., Madrid) through a single-lumen, 114-cm long naso-jejunal 10 F feeding tube whose tip was placed, under fluoroscopic screening, close to Treitz's ligament. The initial infusion rate was 25 ml/h with increases of 25 ml/4 h until requirements were reached.</P>
<P>Control: TPN receive 24-hour continuous infusion of TPN through a central venous catheter (subclavian/ jugular). Venous infusion was started at a rate of 40 ml/h and increased 20 ml/h every 4 hours until the required needs were met.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-06-30 19:10:22 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluate inflammatory response (CRP, TNF-&#945;. IL-6), visceral proteins (pre-albumin, albumin).</P>
<P>Rate of complications (SIRS, MOF, and infections).</P>
<P>Number of surgical interventions.</P>
<P>Length of hospital stay.</P>
<P>Mortality rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-30 19:00:28 +0100" MODIFIED_BY="[Empty name]">
<P>Funding source: Study partially made with/a grant of the Instituto de Salud Carlos III.</P>
<P>Conflict of interest: Not stated.</P>
<P>Calculated sample size: Not stated.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-09-23 13:05:41 +0100" MODIFIED_BY="Cathy Bennett" STUDY_ID="STD-Gupta-2003">
<CHAR_METHODS MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized Controlled Trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-09-23 13:00:00 +0100" MODIFIED_BY="Cathy Bennett">
<P>Number randomised: 21 (3 withdrew after recruitment, and 1 recovered rapidly and was discharged), intervention group 8, control group 9.</P>
<P>Setting: Southampton General Hospital, UK.</P>
<P>Age: &gt;15, mean age of intervention group 65(56-89)P=0.14, mean age of control group 57(38-86).</P>
<P>Sex: Intervention group 4 males and 4 females, control group 3 males and 6 females.</P>
<P>Study period: November 1996 until April 1998.</P>
<P>Diagnostic criteria:</P>
<P>Acute pancreatitis was defined as abdominal pain and a serum amylase concentration of 1,000 U/l or more (normal range 70-300 U/l).</P>
<P>Severe Acute Pancreatitis was established by the presence of an acute physiology, age and chronic health evaluation score (APACHE II) of 6 or more.</P>
<P>Inclusion criteria: Age &gt; 15yrs male or female and all patients admitted with acute pancreatitis.</P>
<P>Exclusion criteria: Pregnant.</P>
<P>Etiology: Intervention group: Biliary stones: 3, Alcohol: 1, Unknown: 4, APACHE II: 8(6-12) P=0.13, CRP: 54(15-254), Control group: Biliary: 3, Alcohol: 5, Unknown: 1, APACHE II:10 (7-14), CRP: 161(16-290)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-06-30 19:13:20 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: TEN delivered by nasojejunal dual lumen tubes (Medicina, Cookson, UK). The weighted nasojejunal tube was passed into the stomach, the patient was encouraged to sit up, or roll onto the right side, and subsequently a radiograph was taken to confirm the placement of the tube.</P>
<P>Control: TPN delivered by a central intravenous line (Arrow triple lumen, Vygon, Cirencester) placed by a standard sterile technique.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-09-23 13:05:41 +0100" MODIFIED_BY="Cathy Bennett">
<P>The aim of the present paper was to report a prospective, randomised comparison of immediate TEN and TPN in patients with predicted severe acute pancreatitis in order to examine the effect of these different feeding regimes on fatigue, oxidative stress, plasma glutamine levels and endotoxaemia (IgG, IgM)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-30 19:13:43 +0100" MODIFIED_BY="[Empty name]">
<P>Funding source: Nutricia</P>
<P>Conflict of interest: Not stated</P>
<P>Calculated sample size: Not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-09-16 15:33:58 +0100" MODIFIED_BY="Cathy Bennett" STUDY_ID="STD-Kalfarentzos-1997">
<CHAR_METHODS MODIFIED="2009-06-25 08:57:16 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-01 08:53:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;span modified=&quot;2009-06-24 15:55:00 +0300&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;no. of males an&lt;/span&gt;&lt;span modified=&quot;2009-06-24 15:56:00 +0300&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;d females from kalfrentzos&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-07-01 08:53:27 +0100" NOTES_MODIFIED_BY="[Empty name]">
<P>Number randomised: 38, intervention group 18, control group 20.<BR/>
</P>
<P>Setting: Patras, Greece.</P>
<P>Sex: Intervention group; 8 males and 10 females, control group; 7 males and 13 females.</P>
<P>Age: Mean age of intervention group 63 +/-10.7, mean age of control group 67.2 +/-8.9</P>
<P>Study Period: July 1990 and December 1995.</P>
<P>Diagnostic Criteria: Severity based on Imrie classification, or APACHE II score, C reactive protein concentration, Balthazar CT scan criteria.</P>
<P>Inclusion criteria: The presence of three or more criteria according to the Imrie classification, or APACHEII score I4 of 8 or more, C-reactive protein concentration greater than 120 mg/l within 48 h of admission, and grade D or E by computed tomography (CT) according to the Balthazar criteria.</P>
<P>Exclusion criteria: Patients who were treated elsewhere for more than 2 days before admission to this hospital were not included.</P>
<P>Etiology: Intervention group: Biliary 14, Alcohol 3, Others 1,</P>
<P>APACHE II: 12.7(2.6) (8-15) (APACHE II) scores were available for seven patients in the EF group and <U>six</U> who had TPN</P>
<P>Imrie classification: 4.2(0.9) (3-5) available for <U>16 patients</U> in the enteral feeding (EF) group and <U>19 </U>in the total parenteral nutrition (TPN) group.</P>
<P>CRP conc.: 290 (157-420) Based on 15 patients in the EF group and 17 in the TPN group.</P>
<P>Balthazar CT Scan score: Grade D: 4(4 out of 11), Grade E: 14 (14 out of 27).</P>
<P>Control group: Biliary 16, Alcohol 2, Others 2, APACHE II: 11.8(1.9) (8-15).</P>
<P>Imrie classification: 4.6 (1.1) (3-6), CRP conc.: 335 (140-513), Balthazar CT Scan score:Grade D: 7, Grade E: 13.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-09-16 15:33:58 +0100" MODIFIED_BY="Cathy Bennett">
<P>Intervention: Patients received enteral nutrition (Rebilan HN; Roussel Ulcef Nutrition, Montpellier, France) through a nasoenteric feeding tube, placed fluoroscopically (Flexifflo 10 fr, 115 cm; Ross Lab, Columbus, Ohio, USA).</P>
<P>Control: Patients received parenteral nutrition containing; crystalline L-amino acid (vamin 18 FE; Kabi Pharmacia, Stockholm, Sweden), carbohydrates in the form of dextrose, fat emulsion (Lipofudin long-chain/medium chain triglycerides 20 per cent; Brain, Melsungen, Germany), vitamins, and minerals through a subclavian central venous line.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-01 06:50:20 +0100" MODIFIED_BY="[Empty name]">
<P>Complications during the course of the disease including death.<BR/>Length of ICU stay.<BR/>Length of hospital stay.<BR/>Number of days on artificial ventilation.<BR/>Number of days receiving tube feeding or TPN.<BR/>Number of antibiotics used, Number of days on antibiotics.<BR/>The mean cost of EN and TPN per day.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-01 06:52:33 +0100" MODIFIED_BY="[Empty name]">
<P>Other outcomes addressed in the study:<BR/>Number of deaths.<BR/>Local septic complications.<BR/>Local other complications.</P>
<P>Systemic sepsis.</P>
<P>Funding source: Not stated.</P>
<P>Conflict of interest: Not stated.</P>
<P>Calculated sample size: not stated.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-01 07:04:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Louie-2005">
<CHAR_METHODS MODIFIED="2009-06-25 18:40:23 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized Controlled Trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-01 06:58:35 +0100" MODIFIED_BY="[Empty name]">
<P>Numer randomised: 28, intervention group 10, control group 18.</P>
<P>Setting: An academic, multi-institutional, tertiary care health system. Teaching hospitals associated with UofA Hospital.</P>
<P>Age: &gt;17, mean age of intervention group: 65.3 (SD 18.3), mean age of control group 59 (SD 15.3).</P>
<P>Sex: Intervention group; 6 males and 4 females, control group; 9 males and 9 females.</P>
<P>Study period: July/15/1999-Dec/15/2001.</P>
<P>Diagnostic Criteria:</P>
<P>For acute pancreatitis:</P>
<P>Quote: "Eligible patients were required to have acute pancreatitis"</P>
<P>Comment: Not stated.</P>
<P>For Severity:</P>
<P>1-Ranson's criteria at admission or diagnosis.</P>
<P>2-CT grading system for pancreatitis of Balthazar and associates.</P>
<P>Inclusion criteria: Patients were required to have acute pancreatitis. A Ransons score (calculated by counting 1 point for each of the criteria met over the 48- hour period) of 3 or greater, and inability to tolerate oral fluids after a maximum time from admission of 96 hours.</P>
<P>Exclusion criteria: Patients were excluded if they did not meet these criteria (Above), If they were younger than 18 years, unable to accept enteral nutrition via the gastrointestinal tract, or already receiving nutritional support.</P>
<P>Etiology: Intervention group: Cancer: 0, TG: 1, ERCP: 0, Biliary stones: 5, Alcohol: 2, Unknown: 2, APACHE II: 11.8 (SD 8.3), Ranson's Score: 4.7 (1.3), Balthazar CT Scan score: 3.4 (SD 1.3).</P>
<P>Control group: Cancer: 0, ERCP: 1, TG: 1, Biliary stones: 7, Alcohol: 4, Unknown: 5 APACHE II: 12.7 (SD 5.5), Ranson's Score: 5 (SD 1.8), Balthazar CT Scan score: 4.2 (SD 0.8).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-01 07:02:37 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: Nasojejunal (NJ) feeding tubes were placed via gastroscopy and confirmed radiographically. Peptamen (Nestl), a semielemental product with low fat content, was infused at 25 mL/h and increased by 10 mL/h every 6 hours, until the target rate was achieved.</P>
<P>Control: In the PN group, long-term vascular catheters were placed percutaneously and confirmed radiographically. PN was initially infused with a 10% dextrose solution and Intralipid (Baxter) at half of the calculated energy requirements; then increased over 2 days to achieve 100% of the target energy rate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-01 07:03:07 +0100" MODIFIED_BY="[Empty name]">
<P>Attenuation of the inflammatory Response.</P>
<P>The effectiveness of nutrition.</P>
<P>The natural history and morbidity of pancreatitis.</P>
<P>The morbidity from each nutritional modality.</P>
<P>An economic evaluation of the nutrition technology</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-01 07:04:46 +0100" MODIFIED_BY="[Empty name]">
<P>Funding source: Not stated.</P>
<P>Conflicts of interest: Non declared.</P>
<P>Ethical approval: Yes.</P>
<P>Sample size calculation: Yes, they conservatively assumed a clinically important difference to be a mean of 2 days, with a standard deviation of 3 days, to achieve a 50% reduction in C-reactive protein levels. To observe a difference between the groups, the total sample size was estimated at 58 participants to achieve an &#945;= 0.05 and a &#946; = 0.2.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-09-16 15:34:23 +0100" MODIFIED_BY="Cathy Bennett" STUDY_ID="STD-McClave-1997">
<CHAR_METHODS MODIFIED="2009-06-25 09:00:23 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-03 15:11:24 +0100" MODIFIED_BY="[Empty name]">
<P>Number randomised: 32, intervention group 16, control group 16.</P>
<P>Age: Mean age of intervention group 47.6 +/-4 years, mean age of control group 45.1+/- 4.2.</P>
<P>Sex: Male.</P>
<P>Study Period: Not stated.</P>
<P>Diagnostic Criteria: Abdominal pain with elevated amylase and lipase, Severity based on Ranson criteria, APACHE III score (<LINK REF="REF-Knaus-1991" TYPE="REFERENCE">Knaus 1991</LINK>), and MOF score.</P>
<P>Inclusion criteria: Male, patients admitted to the hospital with acute pancreatitis or an acute flare of chronic pancreatitis or an acute flare of chronic pancreatitis, characterized by abdominal pain with elevated amylase and lipase.</P>
<P>Exclusion criteria: Females &amp; patients who had an evidence of short bowel syndrome, Crohns disease, major pancreatic resection, failure to start TEN or TPN within 48 hours of admission. After entry into the study patients were excluded if they failed to adhere to dietary restrictions or to the protocol terms for enteral tube placement.</P>
<P>Etiology: Intervention group: EtOH%: 75.0+/-11.2, control group: EtOH%: 62.5+/-12.5.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-03 14:51:24 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: They received enteral nutrition (Peptamen; Clintec Nutrition Company, Deerfeild, IL) through a nasoenteric tube placed endoscopically down into jejunum.<BR/>Control: They received TPN through a central or peripheral venous line.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-01 07:13:03 +0100" MODIFIED_BY="[Empty name]">
<P>Days to diet by mouth which was defined by the point at which the patient showed signs of clinical resolution, and was advanced to clear liquids by mouth.<BR/>Days to normal amylase.<BR/>Length of hospital stay.<BR/>Length of ICU stay.<BR/>Nosocomial infection.<BR/>Mortality.<BR/>Cost of nutritional support which was determined by assigning a dollar amount to endoscopic tube or IV line placement and volume of nutritional hyperalimentation infused.</P>
<P>Other outcomes addressed in the study:</P>
<P>Number of deaths.<BR/>Systemic sepsis.<BR/>Length of hospital stay.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-09-16 15:34:23 +0100" MODIFIED_BY="Cathy Bennett">
<P>Funding source: Supported by a research grant from Clintec nutrition company, Deerfield, Illinois.</P>
<P>Conflict of interest: Not stated.</P>
<P>Calculated sample size: Yes. "Sample size was calculated before the study based on achieving 80% power with a significance level of 0.05. A planned sample size of 20 per group afforded on 80% power to detect a difference of 1.8 days in length of hospitalisation assuming a standard deviation of 2.0 This sample size also afforded an 80% power to detect a $1000 difference in cost, assuming a standard deviation of 1100".</P>
<P>Ethical approval: Yes.</P>
<P>This study only compared males. No females.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-03 14:51:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Olah-2002">
<CHAR_METHODS MODIFIED="2009-07-01 07:32:02 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized Controlled Trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-01 07:39:31 +0100" MODIFIED_BY="[Empty name]">
<P>Number randomised: 89, intervention group 41, control group 48.</P>
<P>Setting: Surgical Ward of the Petz Alada'r Teaching Hospital</P>
<P>Study Period: January 1, 1995 and May 31, 1996.</P>
<P>Age: mean age of intervention group 47.2, mean age of control group 43.8</P>
<P>Sex: intervention group; 33 males and 8 females, control group; 42 males and 6 females.</P>
<P>Diagnostic Critera: Clinical symptoms and laboratory signs of pancreatitis (plasma amylase&gt;200 U/L, normal value &lt;700 U/L) and brief histories of the disease.</P>
<P>Severity Scale:</P>
<P>1- Imrie (Glascow) patients with an Imrie scores of at least 3.</P>
<P>2- C-reactive protein value above 150 mg/L.</P>
<P>3- Severity was defined as a score above 6 on the Second Acute Physiology and Chronic Health Evaluation (APACHEII).</P>
<P>Inclusion criteria: Patients with clinical symptoms and laboratory signs of acute pancreatitis.</P>
<P>Exclusion criteria: Patients with good evidence of biliary tract disease, because those cases required other therapeutic interventions (endoscopic papillotomy, cholecystectomy and/or choledochotomy). Hospitalized patients with acute exacerbations of chronic pancreatitis and those in whom the placement of the feeding tube was not possible (patients unable to cooperate or patients who repeatedly removed their feeding tubes).</P>
<P>Etiology: Intervention Group: Alcohol: 33, Other: 8. Control Group: Alcohol: 39, Other: 9.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-03 14:51:54 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention Group: A nasojejunal tube was placed within 24 h after admittance. The feeding tube (Angiomed duodenal set; 14-F calibre; 4.67 mm; 150 cm long) was inserted into patients stomachs while they were in the surgical ward. The final placement of the tube through the pylorus, which is the most crucial step of the procedure, was performed by a radiologist. The correct position of the jejunal tube was confirmed by x ray. Enteral nutrition was started on the first day through the jejunal feeding tube placed into the second jejunal loop. Survimed OPD (Fresenius) elementary diet was administered (energy: 1 cal/mL protein 22.5 g/500 mL, osmolarity: 400 mOsmol/L). Jejunal feeding was governed by a gravity-driven continuous drip. The dose was increased gradually and the maximum daily intake was reached within 2 to 3 days. The goal was to achieve a 30 kcal/kg of body weight energy intake in this group. Enteral feeding was continued in every patient for a minimum of 5 days and a maximum of 9 days.</P>
<P>Control Group: The therapy protocol was placement of a nasogastric tube, gut rest (no oral feeding) and parenteral nutrition dextrose 10% (3 g/kg body weight), 10% amino acid solution (1 to 1.5 g/kg body weight) and 10% or 20% fat emulsion (0.8 to 1.3 g/kg body weight). The parenteral nutrition was an all-in-one venous admixture in most cases. The goal was to achieve a 30 kcal/kg of body weight energy intake in every patient. Parenteral nutrition was continued for a minimum of 5 days and a maximum of 16 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-01 07:59:11 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: Rates of septic complications, mortality, MOF.</P>
<P>Other outcomes addressed in the study:</P>
<P>Operative Intervention.</P>
<P>Local septic complications.</P>
<P>Other local complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-01 07:59:30 +0100" MODIFIED_BY="[Empty name]">
<P>Funding source: Not stated.</P>
<P>Conflict of interest: Not stated.</P>
<P>Calculated sample size: No.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-03 14:49:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petrov-2006">
<CHAR_METHODS MODIFIED="2009-06-22 12:44:25 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized Controlled Trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-01 08:04:07 +0100" MODIFIED_BY="[Empty name]">
<P>Number randomised 70, intervention group 35, control group 34.</P>
<P>Setting: Intensive Care Unit.</P>
<P>Age: &gt;17 years old, median age (interquartile range) of intervention group 51(42-67), median age (interquartile range) of control group 52(41-70).</P>
<P>Sex: Intervention group 27 females and 8 males, control group 24 females and 10 males.</P>
<P>Diagnostic Criteria: Chemical<B> </B>and biochemical presentation (upper abdominal pain and serum amylase concentration at least 3 times the upper limit of the reference range).</P>
<P>Severity Scale: (APACHEII) score of 8 or more, and/or a C-reactive protein (CRP) level in excess of 150mg/l.</P>
<P>Inclusion criteria: Patients with prognostically severe acute pancreatitis within 72 h of the onset of symptoms.</P>
<P>Exclusion criteria: Age below 18 years and pregnancy.</P>
<P>Etiology: Intervention Group: Biliary (stones): 11, Alcohol: 16, Others: 8, APACHEII: 12(10-14), CRP Conc: 195(146-216), Control Group: Biliary (stones): 13, Alcohol: 15, Others: 6, APACHEII: 12.5(11-16), CRP Conc: 210(177-246).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-01 08:05:15 +0100" MODIFIED_BY="[Empty name]">
<P>For both groups: Nutritional support, supplying daily 30 kcal/kg and 1.5 g/kg of protein, based on ideal body weight, was commenced within 24 h of enrolment, patients received full supportive therapy as required; all patients received analgesia, antibiotic prophylaxis (ofloxacin plus metronidazole) and intravenous fluids.</P>
<P>Intervention: Enteral feeding was through a radiologically placed nasojejunal feeding tube, distal to the ligament of Treitz. The position of a tube was confirmed by X-ray, increased over 48 h to achieve 100% of the target energy rate. The standard enteral feed used was a semi-elemental nutrition (Peptamen, Nestle), which is low in fat and higher in predigested protein than regular tube feeding formulas. Enteral feeding was commenced at a rate of 25 ml/h and increased by 10 ml/h every 6 h, until the desired caloric intake was reached.</P>
<P>Control: TPN was delivered through a central venous catheter, it was initially infused with a 10% dextrose solution, 10% amino acid solution and 10% fat emulsion at half of the calculated energy requirements; then increased over 48 h to achieve 100% of the target energy rate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-01 08:06:34 +0100" MODIFIED_BY="[Empty name]">
<P>Primary Outcome: Incidence of pancreatic infectious complications i.e. infected pancreaticnecrosis and pancreatic abscess during hospital admission.</P>
<P>Other reported outcomes:</P>
<P>Incidence of noninfectious complications.</P>
<P>Frequency of organ failure, (Marshall score was used).</P>
<P>Need for operative intervention.</P>
<P>CRP concentration.</P>
<P>APACHE II score.</P>
<P>Mortality.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-03 14:49:29 +0100" MODIFIED_BY="[Empty name]">
<P>Funding source: Not mentioned.</P>
<P>Conflict of interest: Not mentioned.</P>
<P>Calculated sample size: Yes. "A sample size of 68 patients was calculated in order to demonstrate a reduction of infectious complications in 45% of TPN patients to 12% in TEN patients (alpha 0.05, beta 0.80)."</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-09-16 15:37:17 +0100" MODIFIED_BY="Cathy Bennett" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-07-16 14:02:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bao-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-16 14:02:30 +0100" MODIFIED_BY="[Empty name]">
<P>TPN was given to both groups before initiating EN in the comparison group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-27 23:29:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eckerwall-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-27 23:29:13 +0100" MODIFIED_BY="[Empty name]">
<P>Nasogastric (NG) rather than nasojejunal (NJ) tube was used.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hernandez_x002d_Aranda1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an RCT comparing the effect of TPN versus EN in post operative patients with severe acute pancreatitis. The study did not meet the inclusion criteria as the EN was delivered through a silicon catheter placed into the jejunum intra operatively.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-03 08:39:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Modena-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-03 08:39:12 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-25 18:40:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Powell-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-25 18:40:23 +0100" MODIFIED_BY="[Empty name]">
<P>The study compared TEN to conventional therapy that included I.V antibiotics but no TPN.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-16 15:37:17 +0100" MODIFIED_BY="Cathy Bennett" STUDY_ID="STD-Windsor-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-16 15:37:17 +0100" MODIFIED_BY="Cathy Bennett">
<P>Abstract for the preliminary results for <LINK REF="STD-Windsor-1998" TYPE="STUDY">Windsor 1998</LINK>.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-03 08:40:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Windsor-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-03 08:40:39 +0100" MODIFIED_BY="[Empty name]">
<P>This is an RCT comparing the effect of TPN versus EN in patients with acute pancreatitis. This study did not meet the inclusion criteria as the enteral nutrition was delivered through feeding tube in severe acute pancreatitis patients only, while patients with mild to moderate pancreatitis received nutritional supplements by mouth. Furthermore, the final analysis for the outcomes did not distinguish between patients who received EN through feeding tube or per mouth.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-06-27 23:33:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ye-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-06-27 23:33:27 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison was done between TPN group &amp; PN+EN group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-09-23 13:01:35 +0100" MODIFIED_BY="Cathy Bennett" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-09-16 15:34:48 +0100" MODIFIED_BY="Cathy Bennett">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2009-09-16 15:34:32 +0100" MODIFIED_BY="Cathy Bennett" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-30 18:52:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abou_x002d_Assi-2002">
<DESCRIPTION>
<P>Quote: "For the first 12 months, the study was applied to all patients admitted to our institution with the diagnosis of acute pancreatitis. Then for the 3 months afterward, the data collection was limited to only those patients with acute pancreatitis who were in need of nutritional support"</P>
<P>Comment: Insufficient information to judge</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-30 19:01:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Casas-2007">
<DESCRIPTION>
<P>Quote: "This prospective randomised trial included 22 consecutive patients who were distributed into two groups according to a computerized random number generation".</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 06:44:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-2003">
<DESCRIPTION>
<P>Quote: "Patients were randomised to TPN or TEN using sealed envelopes which had been prepared before the study commenced by a member of our department who had no other involvement with the study. These contained a card on which "Total parenteral nutrition" or "Total enteral nutrition" was written."</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 06:52:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalfarentzos-1997">
<DESCRIPTION>
<P>Qoute: "Patients were assigned on admission to one of two treatment groups by means of numbered envelopes"</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 07:05:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Louie-2005">
<DESCRIPTION>
<P>Quote: "patients were blindly randomised to receive either PN or EN and stratified by hospital, by means of computer- generated assignment placed in sealed, opaque envelopes"</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-16 15:34:32 +0100" MODIFIED_BY="Cathy Bennett" RESULT="UNKNOWN" STUDY_ID="STD-McClave-1997">
<DESCRIPTION>
<P>Qoute: "Upon admission patients were prospectively randomised to receive either TEN or TPN".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-03 14:52:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Olah-2002">
<DESCRIPTION>
<P>Qoute: "89 patients were randomised into the two groups based on their birth dates. Patients who were born between the 1st and 15th of the month were assigned to group A, and patients born between the 16th and 31th were assigned to group B. Group A (<I>n =</I>48) received parenteral nutrition, and group B (<I>n =</I>41) received enteral feedings.</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 08:07:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrov-2006">
<DESCRIPTION>
<P>Qoute: "Patients were randomised at admission by computerized random number generation to receive either enteral or parenteral feeding for a minimum of 7 days"</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-07-01 08:07:11 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-30 18:53:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abou_x002d_Assi-2002">
<DESCRIPTION>
<P>Quote:"of those who did not improve, 19 (12.2%) were randomised to TPN (group TPN) and 20 (12.8%) to jejunal feeding (group EN) during the first 12 months of the study. Subsequently, 14 more patients were randomised in the next 3 months, to reach our goal number of 27 patients on TPN (group TPN) and 26 on jejunal feeding (group EN)"</P>
<P>Comment: Insufficient information to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-30 19:00:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Casas-2007">
<DESCRIPTION>
<P>Quote: "The option corresponding to each patient was placed in sealed envelopes that were opened immediately prior to inclusion".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 06:44:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-2003">
<DESCRIPTION>
<P>Quote: "Patients were randomised to TPN or TEN using sealed envelopes which had been prepared before the study commenced by a member of our department who had no other involvement with the study. These contained a card on which "Total parenteral nutrition" or "Total enteral nutrition" was written."</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kalfarentzos-1997">
<DESCRIPTION>
<P>Not enough information to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 07:06:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Louie-2005">
<DESCRIPTION>
<P>Quote: "patients were blindly randomised to receive either PN or EN and stratified by hospital, by means of computer- generated assignment placed in sealed, opaque envelopes"</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 07:28:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McClave-1997">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 08:00:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Olah-2002">
<DESCRIPTION>
<P>Qoute: "89 patients were randomised into the two groups based on their birth dates"</P>
<P>Comment: Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias due to allocation based on date of birth.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 08:07:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrov-2006">
<DESCRIPTION>
<P>Qoute: "Randomized at admission by computerized random number generation"</P>
<P>Comment: Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-07-01 08:07:20 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-06-25 18:40:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abou_x002d_Assi-2002">
<DESCRIPTION>
<P>Comment:<B> </B>Insufficient information to judge</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-06-30 19:01:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Casas-2007">
<DESCRIPTION>
<P>Not addressed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-2003">
<DESCRIPTION>
<P>The study did not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-07-01 06:52:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kalfarentzos-1997">
<DESCRIPTION>
<P>The study did not address this outcome.</P>
<P>Comment: Probably not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-06-25 18:40:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Louie-2005">
<DESCRIPTION>
<P>Comment:The study did not address this.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-07-01 07:28:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McClave-1997">
<DESCRIPTION>
<P>The study did not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-07-01 08:01:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Olah-2002">
<DESCRIPTION>
<P>The study did not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-07-01 08:07:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Petrov-2006">
<DESCRIPTION>
<P>The study did not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-07-01 08:07:39 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-06-25 18:40:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abou_x002d_Assi-2002">
<DESCRIPTION>
<P>Comment:<B> </B>No missing data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Casas-2007">
<DESCRIPTION>
<P>All 22 patients completed the study. No missing data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-2003">
<DESCRIPTION>
<P>No missing data. All 17 patients completed the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalfarentzos-1997">
<DESCRIPTION>
<P>No missing data. All 38 participants completed the study. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-01 07:06:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Louie-2005">
<DESCRIPTION>
<P>Quote: "In all, 28 patients consented to participate and completed the study"</P>
<P>Comment: No missing data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-01 07:29:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McClave-1997">
<DESCRIPTION>
<P>No missing data all; 32 participants completed the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-01 08:01:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Olah-2002">
<DESCRIPTION>
<P>No missing data from outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-01 08:07:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrov-2006">
<DESCRIPTION>
<P>Qoute: "A total of 70 patients were randomised to receive either enteral or parenteral feeding. One patient who met the entry criteria was found at operation to have an acute mesenteric infarction and was thereby excluded from the study, leaving 35 patients in the TEN group, and 34 in the TPN group clinical characteristics of the two groups were similar".</P>
<P>Comment: No missing data, except for one who was excluded for acute mesenteric infarction.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2009-07-01 08:07:44 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-30 18:54:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abou_x002d_Assi-2002">
<DESCRIPTION>
<P>Comments: All outcomes stated in the methods were mentioned in the results section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-30 19:05:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Casas-2007">
<DESCRIPTION>
<P>All outcomes mentioned in the introduction and methods were addressed in the results section. The authors were contacted and provided missing data and details of statistical methods used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gupta-2003">
<DESCRIPTION>
<P>Comments: All outcomes stated in the methods were mentioned in the results section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalfarentzos-1997">
<DESCRIPTION>
<P>All expected outcomes are addressed in detail in the methods section in terms of measurements and appear in the results section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 07:05:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Louie-2005">
<DESCRIPTION>
<P>Comment: Probably yes, because all primary and secondary outcomes stated in the introduction were clearly presented in the result section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 07:31:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McClave-1997">
<DESCRIPTION>
<P>All expected outcomes are addressed in detail in the methods section in terms of measurements and appear in the results section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-25 18:40:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Olah-2002">
<DESCRIPTION>
<P>All expected outcomes are addressed in detail in the methods section in terms of measurements and appear in the results section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-01 08:07:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrov-2006">
<DESCRIPTION>
<P>All expected outcomes are addressed in detail in the methods section in terms of measurements and appear in the results section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2009-09-16 15:34:48 +0100" MODIFIED_BY="Cathy Bennett" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-25 18:40:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abou_x002d_Assi-2002">
<DESCRIPTION>
<P></P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-25 18:40:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Casas-2007">
<DESCRIPTION>
<P></P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-30 10:59:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gupta-2003">
<DESCRIPTION>
<P>Comment: The study was supported by a grant from Nutricia, their product Nutrison was used for the TEN group. The study did not address whether Nutricia was or was not involved in the study design or approving the final paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-22 17:56:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalfarentzos-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-25 18:40:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Louie-2005">
<DESCRIPTION>
<P></P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-16 15:34:48 +0100" MODIFIED_BY="Cathy Bennett" RESULT="UNKNOWN" STUDY_ID="STD-McClave-1997">
<DESCRIPTION>
<P>Their source of funding provided the nutritional product for the intervention group, and they did not address whether or not they were involved in the design, results or approval of the final paper.</P>
<P>Secondly, the study was terminated early because of longer than anticipated duration of the study, difficulty in compliance and obtaining consent. Although a fairly reasonable explanation was provided, this may have masked reporting of some serious outcomes such as mortality.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-22 12:04:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Olah-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-06-22 13:57:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petrov-2006">
<DESCRIPTION>
<P></P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2009-07-16 14:11:56 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2009-07-16 14:11:56 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2009-07-16 14:11:44 +0100" MODIFIED_BY="Grade Profiler">Enteral compared to parenteral nutrition for acute pancreatitis</TITLE>
<TABLE COLS="7" ROWS="8">
<TR>
<TD COLSPAN="7">
<P>
<B>Enteral compared to parenteral nutrition for acute pancreatitis</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with acute pancreatitis<BR/>
<B>Settings:</B> Hospitals<BR/>
<B>Intervention:</B> Enteral<BR/>
<B>Comparison: </B>Parenteral nutrition</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Parenteral nutrition</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Enteral</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Mortality</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>158 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>79 per 1000</B>
<BR/>(44 to 144)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.5 </B>
<BR/>(0.28 to 0.91)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>348<BR/>(8 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Length of hospital stay</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean Length of hospital stay in the intervention groups was<BR/>
<B>2.37 lower</B>
<BR/>(7.18 lower to 2.44 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>145<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Multiple Organ Failure(MOF)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>347 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>191 per 1000</B>
<BR/>(128 to 281)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.55 </B>
<BR/>(0.37 to 0.81)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>278<BR/>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Operative Intervention</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>335 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>154 per 1000</B>
<BR/>(87 to 275)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.46 </B>
<BR/>(0.26 to 0.82)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>316<BR/>(7 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Systemic infection</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>311 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>121 per 1000</B>
<BR/>(72 to 202)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.39 </B>
<BR/>(0.23 to 0.65)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>259<BR/>(7 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Local septic complications</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>183 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>135 per 1000</B>
<BR/>(73 to 247)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.74 </B>
<BR/>(0.4 to 1.35)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>246<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> (McClave 1997) was underpowered and had reported no deaths in both groups this could be either because the population included patiens with mild acute pancreatitis who generally have good prognosis as described in (Abou-Assi 2002) or death could have been masked because the study was terminated early due to difficulties in compliance and obtaining consent.<BR/>
<SUP>2</SUP> The majority of studies were of small sample size and with wide confidence intervals only one study (Petrov 2006) had significant results.<BR/>
<SUP>3</SUP> (McClave 1997) was terminated early and that probably affected the actual length of hospital stay.<BR/>
<SUP>4</SUP> The majority of studies were of small sample size and with wide confidence intervals only one study (Petrov 2006) had significant results.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2009-06-30 21:56:46 +0100" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-08-02 05:19:55 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2009-08-02 05:19:55 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<DICH_OUTCOME CHI2="7.839357130429979" CI_END="0.9090493037903437" CI_START="0.279300814976733" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.503883132683239" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="29" I2="36.219259860077884" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.0414125614607551" LOG_CI_START="-0.5539277970616816" LOG_EFFECT_SIZE="-0.2976701792612183" METHOD="MH" MODIFIED="2009-08-02 05:19:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16531410802210078" P_Q="0.0" P_Z="0.022803887181833196" Q="0.0" RANDOM="NO" SCALE="141.85" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="165" TOTAL_2="183" WEIGHT="99.99999999999999" Z="2.2767043400749007">
<NAME>Mortality</NAME>
<GROUP_LABEL_1>Favours EN</GROUP_LABEL_1>
<GROUP_LABEL_2>TPN</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.6218911524683435" CI_START="0.05490002686607154" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7498824328153585" LOG_CI_START="-1.2604274430219706" LOG_EFFECT_SIZE="-0.255272505103306" ORDER="892" O_E="0.0" SE="1.1808659722612234" STUDY_ID="STD-Kalfarentzos-1997" TOTAL_1="18" TOTAL_2="20" VAR="1.3944444444444444" WEIGHT="6.600145232815434"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="893" O_E="0.0" SE="0.0" STUDY_ID="STD-McClave-1997" TOTAL_1="16" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.034025870258138" CI_START="0.11293680320538402" EFFECT_SIZE="0.5853658536585366" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.48201927956951673" LOG_CI_START="-0.9471645095857756" LOG_EFFECT_SIZE="-0.23257261500812948" MODIFIED="2009-06-23 07:14:04 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="12" O_E="0.0" SE="0.8395096323236724" STUDY_ID="STD-Olah-2002" TOTAL_1="41" TOTAL_2="48" VAR="0.7047764227642276" WEIGHT="12.83773567131891"/>
<DICH_DATA CI_END="3.444179520074065" CI_START="0.556637582953975" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5370857799899964" LOG_CI_START="-0.2544274743970579" LOG_EFFECT_SIZE="0.1413291527964693" MODIFIED="2009-06-25 16:44:16 +0100" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.46493880368075446" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="26" TOTAL_2="27" VAR="0.21616809116809116" WEIGHT="20.506111603841664"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-23 07:13:31 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="10" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.34605885196235" CI_START="0.014009742356750798" EFFECT_SIZE="0.24675324675324675" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.6380956030037057" LOG_CI_START="-1.8535698514430117" LOG_EFFECT_SIZE="-0.6077371242196529" MODIFIED="2009-06-23 07:05:43 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="11" O_E="0.0" SE="1.4636166218849205" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="2.142173615857826" WEIGHT="8.940752292230538"/>
<DICH_DATA CI_END="0.6702230618399054" CI_START="0.03911108617402233" EFFECT_SIZE="0.1619047619047619" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17378063251761303" LOG_CI_START="-1.4077001228657153" LOG_EFFECT_SIZE="-0.7907403776916642" MODIFIED="2009-06-23 07:13:00 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="13" O_E="0.0" SE="0.724810416630461" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.5253501400560224" WEIGHT="42.40673023982864"/>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213574" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2009-06-23 07:11:54 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="9" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="8.708524959964809"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.359458246530093" CI_END="0.771507381665708" CI_START="0.19560391640317132" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.38847118990701063" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.11265991431716761" LOG_CI_START="-0.7086224539693858" LOG_EFFECT_SIZE="-0.4106411841432767" METHOD="MH" MODIFIED="2009-07-02 14:32:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.49890487498321323" P_Q="0.0" P_Z="0.006913515999535023" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="165" TOTAL_2="183" WEIGHT="100.0" Z="2.700981615251787">
<NAME>Mortality in patients with acute pancreatitis excluding those from (Abou-Assi 2002) in which death resulted after resolution of acute pancreatitis and was attributed to other causes; cardiac surgery, cancer of the liver, squamous cell carcinoma of the pharynx and intracerebral hemorrhage.</NAME>
<GROUP_LABEL_1>Favours EN</GROUP_LABEL_1>
<GROUP_LABEL_2>TPN</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.6218911524683435" CI_START="0.05490002686607154" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7498824328153585" LOG_CI_START="-1.2604274430219706" LOG_EFFECT_SIZE="-0.255272505103306" ORDER="129" O_E="0.0" SE="1.1808659722612234" STUDY_ID="STD-Kalfarentzos-1997" TOTAL_1="18" TOTAL_2="20" VAR="1.3944444444444444" WEIGHT="7.08438950564132"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="130" O_E="0.0" SE="0.0" STUDY_ID="STD-McClave-1997" TOTAL_1="16" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.723748527938576" CI_START="0.2896012871902756" EFFECT_SIZE="1.0384615384615385" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5709803445391041" LOG_CI_START="-0.5381995121627653" LOG_EFFECT_SIZE="0.016390416188169384" MODIFIED="2009-07-02 14:32:43 +0100" MODIFIED_BY="[Empty name]" ORDER="132" O_E="0.0" SE="0.6515377383555189" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="26" TOTAL_2="27" VAR="0.42450142450142453" WEIGHT="14.673745978141769"/>
<DICH_DATA CI_END="3.034025870258138" CI_START="0.11293680320538402" EFFECT_SIZE="0.5853658536585366" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.48201927956951673" LOG_CI_START="-0.9471645095857756" LOG_EFFECT_SIZE="-0.23257261500812948" ORDER="131" O_E="0.0" SE="0.8395096323236724" STUDY_ID="STD-Olah-2002" TOTAL_1="41" TOTAL_2="48" VAR="0.7047764227642276" WEIGHT="13.779624032196226"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="133" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.34605885196235" CI_START="0.014009742356750798" EFFECT_SIZE="0.24675324675324675" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.6380956030037057" LOG_CI_START="-1.8535698514430117" LOG_EFFECT_SIZE="-0.6077371242196529" ORDER="134" O_E="0.0" SE="1.4636166218849205" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="2.142173615857826" WEIGHT="9.596723932178937"/>
<DICH_DATA CI_END="0.6702230618399054" CI_START="0.03911108617402233" EFFECT_SIZE="0.1619047619047619" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17378063251761303" LOG_CI_START="-1.4077001228657153" LOG_EFFECT_SIZE="-0.7907403776916642" ORDER="135" O_E="0.0" SE="0.724810416630461" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.5253501400560224" WEIGHT="45.518058176342784"/>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213574" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="136" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="9.347458375498963"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.07278951733215894" CI_END="0.5767309336401539" CI_START="0.056216496478119715" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.18006052454606591" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.23902675407040122" LOG_CI_START="-1.2501362239657205" LOG_EFFECT_SIZE="-0.744581489018061" METHOD="MH" MODIFIED="2009-07-02 15:10:40 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.964259569036039" P_Q="0.0" P_Z="0.003893834330014713" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="72" WEIGHT="100.00000000000001" Z="2.8866367994391204">
<NAME>Mortality in patients with severe acute pancreatitis (SAP)</NAME>
<GROUP_LABEL_1>Favours EN</GROUP_LABEL_1>
<GROUP_LABEL_2>TPN</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="140" O_E="0.0" SE="0.0" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.34605885196235" CI_START="0.014009742356750798" EFFECT_SIZE="0.24675324675324675" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.6380956030037057" LOG_CI_START="-1.8535698514430117" LOG_EFFECT_SIZE="-0.6077371242196529" ORDER="142" O_E="0.0" SE="1.4636166218849205" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="2.142173615857826" WEIGHT="14.887357094821791"/>
<DICH_DATA CI_END="0.6702230618399054" CI_START="0.03911108617402233" EFFECT_SIZE="0.1619047619047619" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17378063251761303" LOG_CI_START="-1.4077001228657153" LOG_EFFECT_SIZE="-0.7907403776916642" ORDER="141" O_E="0.0" SE="0.724810416630461" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.5253501400560224" WEIGHT="70.61197041022193"/>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213574" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="139" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="14.500672494956287"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2009-08-02 03:56:22 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<CONT_OUTCOME CHI2="0.607703262721035" CI_END="2.4378198904958372" CI_START="-7.175951680854824" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.369065895179493" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2009-08-02 03:56:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8946666524432088" P_Q="1.0" P_Z="0.33406166512311253" Q="0.0" RANDOM="NO" SCALE="42.32" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="74" UNITS="" WEIGHT="100.0" Z="0.9659650839616537">
<NAME>Length of hospital stay</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.169754711254333" CI_START="-10.169754711254333" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="40.0" MEAN_2="39.0" MODIFIED="2009-06-29 07:18:32 +0100" MODIFIED_BY="[Empty name]" ORDER="43" SD_1="17.72" SD_2="17.34" SE="5.698959164229513" STUDY_ID="STD-Kalfarentzos-1997" TOTAL_1="18" TOTAL_2="20" WEIGHT="18.5199723598406"/>
<CONT_DATA CI_END="5.853050841547342" CI_START="-10.253050841547344" EFFECT_SIZE="-2.200000000000001" ESTIMABLE="YES" MEAN_1="9.7" MEAN_2="11.9" MODIFIED="2009-06-23 11:38:15 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="894" SD_1="7.35" SD_2="14.7" SE="4.108774908655863" STUDY_ID="STD-McClave-1997" TOTAL_1="16" TOTAL_2="16" WEIGHT="35.62925360584469"/>
<CONT_DATA CI_END="3.247999689448119" CI_START="-11.647999689448117" EFFECT_SIZE="-4.199999999999999" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="18.4" MODIFIED="2009-06-23 11:00:44 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="134" SD_1="13.83" SD_2="13.83" SE="3.800069668727073" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="26" TOTAL_2="27" WEIGHT="41.653193764263314"/>
<CONT_DATA CI_END="22.961960443002425" CI_START="-23.961960443002425" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="30.2" MEAN_2="30.7" MODIFIED="2009-06-29 07:17:03 +0100" MODIFIED_BY="[Empty name]" ORDER="52" SD_1="32.0" SD_2="23.5" SE="11.970607943853752" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" WEIGHT="4.197580270051385"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.27376262136967433" CI_END="2.8668523667788985" CI_START="-15.404775680520851" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.268961656870976" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2009-07-03 18:53:41 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6008189240744831" P_Q="1.0" P_Z="0.17865106825629626" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="24" UNITS="" WEIGHT="100.0" Z="1.3449200077981522">
<NAME>Subgroup analysis for length of hospital stay in patients with severe acute pancreatitis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.618657187239437" CI_START="-17.218657187239437" EFFECT_SIZE="-7.300000000000001" ESTIMABLE="YES" MEAN_1="12.8" MEAN_2="20.1" MODIFIED="2009-07-02 15:31:49 +0100" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="8.2" SD_2="16.3" SE="5.060632371551998" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="13" TOTAL_2="13" WEIGHT="84.83767142457319"/>
<CONT_DATA CI_END="22.961960443002425" CI_START="-23.961960443002425" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="30.2" MEAN_2="30.7" ORDER="137" SD_1="32.0" SD_2="23.5" SE="11.970607943853752" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" WEIGHT="15.16232857542681"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2009-07-03 18:54:26 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.887633468579433" CI_START="0.16984752962912952" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.7699407654041357" LOG_CI_START="-0.7699407654041358" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2009-07-03 18:54:26 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="11" WEIGHT="100.0" Z="0.0">
<NAME>Systemic Inflammatory Response Response Syndrome(SIRS)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.887633468579433" CI_START="0.16984752962912952" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7699407654041357" LOG_CI_START="-0.7699407654041358" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-23 07:37:25 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="27" O_E="0.0" SE="0.9045340337332909" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="0.8181818181818181" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2009-07-01 09:25:08 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<DICH_OUTCOME CHI2="9.291042986120136" CI_END="0.8106108830688981" CI_START="0.37343355103874554" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5501902403488015" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="51" I2="46.18472858785083" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.09118756982077493" LOG_CI_START="-0.42778666556100453" LOG_EFFECT_SIZE="-0.2594871176908897" METHOD="MH" MODIFIED="2009-06-29 12:28:00 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.09800359150714999" P_Q="0.0" P_Z="0.002511885789784934" Q="0.0" RANDOM="NO" SCALE="192.96" SORT_BY="YEAR" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="131" TOTAL_2="147" WEIGHT="100.00000000000001" Z="3.0219059502093923">
<NAME>Multiple Organ Failure(MOF)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1464679634509705" CI_START="0.38465601452664633" EFFECT_SIZE="0.9086538461538461" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3317244109145529" LOG_CI_START="-0.41492747249358775" LOG_EFFECT_SIZE="-0.041601530789517414" MODIFIED="2009-06-23 07:47:46 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="28" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="26" TOTAL_2="27" VAR="0.19235856735856735" WEIGHT="16.47376943565124"/>
<DICH_DATA CI_END="2.287150902874574" CI_START="0.09588262698678347" EFFECT_SIZE="0.4682926829268293" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3592948196673908" LOG_CI_START="-1.0182600756997626" LOG_EFFECT_SIZE="-0.3294826280161859" MODIFIED="2009-06-23 07:50:24 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="34" O_E="0.0" SE="0.8091825645453735" STUDY_ID="STD-Olah-2002" TOTAL_1="41" TOTAL_2="48" VAR="0.6547764227642275" WEIGHT="9.668728658078583"/>
<DICH_DATA CI_END="1.3129135571182542" CI_START="0.0055640643442649304" EFFECT_SIZE="0.08547008547008547" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11823613286602475" LOG_CI_START="-2.254607856358348" LOG_EFFECT_SIZE="-1.0681858617461617" MODIFIED="2009-06-23 07:49:30 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="30" O_E="0.0" SE="1.3938203050375764" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="1.9427350427350425" WEIGHT="12.924322402640858"/>
<DICH_DATA CI_END="1.5927355442175637" CI_START="0.5898080741867011" EFFECT_SIZE="0.9692307692307692" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.2021436720839904" LOG_CI_START="-0.22928928646253816" LOG_EFFECT_SIZE="-0.01357280718927387" MODIFIED="2009-06-23 07:49:13 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="32" O_E="0.0" SE="0.25342585547781865" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="0.06422466422466422" WEIGHT="19.489057591283835"/>
<DICH_DATA CI_END="0.8408698744882109" CI_START="0.1902791440796744" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.07527120653764877" LOG_CI_START="-0.7206088108064265" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2009-06-23 07:47:30 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="35" O_E="0.0" SE="0.3790745032201409" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.14369747899159663" WEIGHT="36.19706794546139"/>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213574" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2009-06-23 07:48:06 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="29" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="5.247053966884109"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.762746308705793" CI_END="1.2892345339696292" CI_START="0.1611935323679306" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.45586869664552243" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="38" I2="69.27094175001976" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.11033193018778077" LOG_CI_START="-0.7926523875512036" LOG_EFFECT_SIZE="-0.3411602286817114" METHOD="MH" MODIFIED="2009-07-01 09:25:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.02069439464187106" P_Q="0.0" P_Z="0.13860546750067076" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.6097710879648163" TOTALS="YES" TOTAL_1="64" TOTAL_2="72" WEIGHT="100.0" Z="1.4810041504328448">
<NAME>MOF in Severe Acute Pancreatitis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.7419210762620905" CI_START="0.01068969633105066" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5730946232213574" LOG_CI_START="-1.9710346318933951" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="146" O_E="0.0" SE="1.4944341180973262" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.233333333333333" WEIGHT="9.89561543125432"/>
<DICH_DATA CI_END="1.3129135571182542" CI_START="0.0055640643442649304" EFFECT_SIZE="0.08547008547008547" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11823613286602475" LOG_CI_START="-2.254607856358348" LOG_EFFECT_SIZE="-1.0681858617461617" ORDER="143" O_E="0.0" SE="1.3938203050375764" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="1.9427350427350425" WEIGHT="11.022213676858577"/>
<DICH_DATA CI_END="1.5927355442175637" CI_START="0.5898080741867011" EFFECT_SIZE="0.9692307692307692" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.2021436720839904" LOG_CI_START="-0.22928928646253816" LOG_EFFECT_SIZE="-0.01357280718927387" ORDER="144" O_E="0.0" SE="0.25342585547781865" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="0.06422466422466422" WEIGHT="41.7425004425784"/>
<DICH_DATA CI_END="0.8408698744882109" CI_START="0.1902791440796744" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.07527120653764877" LOG_CI_START="-0.7206088108064265" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="145" O_E="0.0" SE="0.3790745032201409" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.14369747899159663" WEIGHT="37.339670449308706"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2009-07-03 07:47:31 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<DICH_OUTCOME CHI2="7.94270486372492" CI_END="0.6654993580383207" CI_START="0.28843360841644616" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4381237054050161" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="56" I2="24.458983394906635" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-0.17685235912326455" LOG_CI_START="-0.5399541368117915" LOG_EFFECT_SIZE="-0.358403247967528" METHOD="MH" MODIFIED="2009-07-03 07:47:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2423312515612268" P_Q="0.0" P_Z="1.0919117414261583E-4" Q="0.0" RANDOM="NO" SCALE="264.29" SORT_BY="YEAR" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="149" TOTAL_2="167" WEIGHT="100.0" Z="3.8692041797774386">
<NAME>Operative Intervention</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9162403209036782" CI_START="0.10022192044994149" EFFECT_SIZE="0.30303030303030304" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.037990600182003" LOG_CI_START="-0.9990372795737719" LOG_EFFECT_SIZE="-0.5185139398778874" MODIFIED="2009-06-23 07:57:53 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="39" O_E="0.0" SE="0.5645235767325122" STUDY_ID="STD-Kalfarentzos-1997" TOTAL_1="18" TOTAL_2="20" VAR="0.31868686868686863" WEIGHT="19.069200565017955"/>
<DICH_DATA CI_END="103.10973856885289" CI_START="0.26075272595818233" EFFECT_SIZE="5.185185185185185" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.013299685719767" LOG_CI_START="-0.5837711426812656" LOG_EFFECT_SIZE="0.7147642715192507" MODIFIED="2009-06-23 08:02:35 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="36" O_E="0.0" SE="1.5255322603107013" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="26" TOTAL_2="27" VAR="2.327248677248677" WEIGHT="0.8983011836413417"/>
<DICH_DATA CI_END="1.4058759151873412" CI_START="0.20142919115041746" EFFECT_SIZE="0.532150776053215" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.14794699086336774" LOG_CI_START="-0.6958775911960768" LOG_EFFECT_SIZE="-0.2739653001663545" MODIFIED="2009-06-23 08:04:47 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="42" O_E="0.0" SE="0.4956667365007647" STUDY_ID="STD-Olah-2002" TOTAL_1="41" TOTAL_2="48" VAR="0.2456855136733185" WEIGHT="18.54545223489262"/>
<DICH_DATA CI_END="7.674562832319093" CI_START="0.3710512653578078" EFFECT_SIZE="1.6875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8850536460490437" LOG_CI_START="-0.4305660830429185" LOG_EFFECT_SIZE="0.22724378150306254" MODIFIED="2009-06-23 08:04:35 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="38" O_E="0.0" SE="0.7728015412913085" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="0.5972222222222221" WEIGHT="3.4444664122195237"/>
<DICH_DATA CI_END="3.4970589781086274" CI_START="0.057905800636373995" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.5437029567733966" LOG_CI_START="-1.2372779292227094" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2009-06-23 08:03:31 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="40" O_E="0.0" SE="1.046156988431681" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="1.0944444444444443" WEIGHT="5.2282079471189205"/>
<DICH_DATA CI_END="0.5902255633945556" CI_START="0.16372073535674558" EFFECT_SIZE="0.31085714285714283" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="-0.22898198460093697" LOG_CI_START="-0.7858963133752922" LOG_EFFECT_SIZE="-0.5074391489881146" MODIFIED="2009-06-23 08:01:54 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="43" O_E="0.0" SE="0.3271342334924443" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.10701680672268907" WEIGHT="46.40981692188897"/>
<DICH_DATA CI_END="2.477374703175844" CI_START="0.00823781854200097" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3939916986384896" LOG_CI_START="-2.0841877786670033" LOG_EFFECT_SIZE="-0.8450980400142569" MODIFIED="2009-06-23 08:03:59 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="37" O_E="0.0" SE="1.455694892155502" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.1190476190476186" WEIGHT="6.404554735220677"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.572908399843171" CI_END="0.655675645489099" CI_START="0.22291420241010695" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.38230800874940424" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="34" I2="34.39623675595851" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-0.1833109475308748" LOG_CI_START="-0.6518622606725442" LOG_EFFECT_SIZE="-0.41758660410170945" METHOD="MH" MODIFIED="2009-07-01 09:26:51 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2058785492324906" P_Q="0.0" P_Z="4.766362158611178E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="72" WEIGHT="100.0" Z="3.4935542021126373">
<NAME>Operative intervention in SAP</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.477374703175844" CI_START="0.00823781854200097" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3939916986384896" LOG_CI_START="-2.0841877786670033" LOG_EFFECT_SIZE="-0.8450980400142569" ORDER="150" O_E="0.0" SE="1.455694892155502" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.1190476190476186" WEIGHT="10.416104122984583"/>
<DICH_DATA CI_END="7.674562832319093" CI_START="0.3710512653578078" EFFECT_SIZE="1.6875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8850536460490437" LOG_CI_START="-0.4305660830429185" LOG_EFFECT_SIZE="0.22724378150306254" ORDER="147" O_E="0.0" SE="0.7728015412913085" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="0.5972222222222221" WEIGHT="5.601938351857255"/>
<DICH_DATA CI_END="3.4970589781086274" CI_START="0.057905800636373995" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.5437029567733966" LOG_CI_START="-1.2372779292227094" LOG_EFFECT_SIZE="-0.3467874862246563" ORDER="148" O_E="0.0" SE="1.046156988431681" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="1.0944444444444443" WEIGHT="8.502942141211905"/>
<DICH_DATA CI_END="0.5902255633945556" CI_START="0.16372073535674558" EFFECT_SIZE="0.31085714285714283" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="-0.22898198460093697" LOG_CI_START="-0.7858963133752922" LOG_EFFECT_SIZE="-0.5074391489881146" ORDER="149" O_E="0.0" SE="0.3271342334924443" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.10701680672268907" WEIGHT="75.47901538394626"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2009-07-01 11:49:35 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<DICH_OUTCOME CHI2="3.757760436515482" CI_END="0.649464984873173" CI_START="0.22843619303792081" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3851769835489375" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="42" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-0.18744425842665313" LOG_CI_START="-0.6412350861031356" LOG_EFFECT_SIZE="-0.4143396722648944" METHOD="MH" MODIFIED="2009-06-25 15:14:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.709418788776615" P_Q="0.0" P_Z="3.447245382527884E-4" Q="0.0" RANDOM="NO" SCALE="89.95" SORT_BY="YEAR" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="135" WEIGHT="99.99999999999999" Z="3.5791416902956">
<NAME>Systemic infection</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.445397859258201" CI_START="0.2617161038139376" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.38834952768196396" LOG_CI_START="-0.5821695536980767" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="896" O_E="0.0" SE="0.570087712549569" STUDY_ID="STD-McClave-1997" TOTAL_1="16" TOTAL_2="16" VAR="0.325" WEIGHT="12.140291831932114"/>
<DICH_DATA CI_END="1.0456114324768762" CI_START="0.15612745139025938" EFFECT_SIZE="0.40404040404040403" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.019370323075240635" LOG_CI_START="-0.8065207296144157" LOG_EFFECT_SIZE="-0.3935752032695875" MODIFIED="2009-06-23 08:16:54 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="895" O_E="0.0" SE="0.485132492576549" STUDY_ID="STD-Kalfarentzos-1997" TOTAL_1="18" TOTAL_2="20" VAR="0.23535353535353537" WEIGHT="25.30292402865851"/>
<DICH_DATA CI_END="0.8479565142472351" CI_START="0.015700816308103552" EFFECT_SIZE="0.11538461538461539" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07162641909554397" LOG_CI_START="-1.8040777674067667" LOG_EFFECT_SIZE="-0.9378520932511555" MODIFIED="2009-06-23 08:15:25 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="44" O_E="0.0" SE="1.0176504977704948" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="26" TOTAL_2="27" VAR="1.0356125356125356" WEIGHT="21.440213499412184"/>
<DICH_DATA CI_END="15.193081907400494" CI_START="0.08330271683610938" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1816458791699729" LOG_CI_START="-1.0793408342752102" LOG_EFFECT_SIZE="0.05115252244738129" MODIFIED="2009-06-23 08:20:08 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="46" O_E="0.0" SE="1.3281147875424355" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="1.7638888888888888" WEIGHT="2.2852314036578094"/>
<DICH_DATA CI_END="6.5618249936111335" CI_START="0.018186837212421824" EFFECT_SIZE="0.34545454545454546" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.8170246434041122" LOG_CI_START="-1.740242820486942" LOG_EFFECT_SIZE="-0.4616090885414149" MODIFIED="2009-06-23 08:13:22 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="47" O_E="0.0" SE="1.502151566967708" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="2.2564593301435405" WEIGHT="4.451440338375108"/>
<DICH_DATA CI_END="1.0019335308578083" CI_START="0.12454246198601517" EFFECT_SIZE="0.35324675324675325" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="8.389110130767323E-4" LOG_CI_START="-0.9046825532896432" LOG_EFFECT_SIZE="-0.45192182113828316" MODIFIED="2009-06-23 08:18:04 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="49" O_E="0.0" SE="0.5319077905349573" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.28292589763178" WEIGHT="27.095723798805004"/>
<DICH_DATA CI_END="2.7308121996385246" CI_START="0.04068793567196556" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4362918343524308" LOG_CI_START="-1.390534343791756" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2009-06-23 08:18:09 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="45" O_E="0.0" SE="1.0730867399773196" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="1.1515151515151516" WEIGHT="7.284175099159268"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6983857822254488" CI_END="0.9008872477762375" CI_START="0.17036850109258256" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.39176882221159415" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-0.04532956055567008" LOG_CI_START="-0.7686106975165466" LOG_EFFECT_SIZE="-0.4069701290361083" METHOD="MH" MODIFIED="2009-07-01 11:49:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8735835832061575" P_Q="0.0" P_Z="0.027409624451128003" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="72" WEIGHT="100.0" Z="2.205634171647247">
<NAME>Systemic infection in SAP</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.193081907400494" CI_START="0.08330271683610938" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1816458791699729" LOG_CI_START="-1.0793408342752102" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="261" O_E="0.0" SE="1.3281147875424355" STUDY_ID="STD-Gupta-2003" TOTAL_1="8" TOTAL_2="9" VAR="1.7638888888888888" WEIGHT="5.557932891987816"/>
<DICH_DATA CI_END="6.5618249936111335" CI_START="0.018186837212421824" EFFECT_SIZE="0.34545454545454546" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.8170246434041122" LOG_CI_START="-1.740242820486942" LOG_EFFECT_SIZE="-0.4616090885414149" ORDER="262" O_E="0.0" SE="1.502151566967708" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="2.2564593301435405" WEIGHT="10.826390112517933"/>
<DICH_DATA CI_END="1.0019335308578083" CI_START="0.12454246198601517" EFFECT_SIZE="0.35324675324675325" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="8.389110130767323E-4" LOG_CI_START="-0.9046825532896432" LOG_EFFECT_SIZE="-0.45192182113828316" ORDER="263" O_E="0.0" SE="0.5319077905349573" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="0.28292589763178" WEIGHT="65.89976590228308"/>
<DICH_DATA CI_END="2.7308121996385246" CI_START="0.04068793567196556" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4362918343524308" LOG_CI_START="-1.390534343791756" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="264" O_E="0.0" SE="1.0730867399773196" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="1.1515151515151516" WEIGHT="17.715911093211165"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2009-07-03 18:57:27 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<DICH_OUTCOME CHI2="6.954447030307031" CI_END="1.345715175571737" CI_START="0.40360030166288496" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7369742538332498" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" I2="42.48284611891846" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.12895314995700383" LOG_CI_START="-0.3940485178303764" LOG_EFFECT_SIZE="-0.13254768393668626" METHOD="MH" MODIFIED="2009-07-03 15:16:16 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.13831533293622789" P_Q="0.0" P_Z="0.320489445738361" Q="0.0" RANDOM="NO" SCALE="307.89" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="115" TOTAL_2="131" WEIGHT="100.0" Z="0.9934526130640071">
<NAME>Local septic complications</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6794711630264745" CI_START="0.11518764581889715" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.428049087445737" LOG_CI_START="-0.9385940976523491" LOG_EFFECT_SIZE="-0.255272505103306" ORDER="897" O_E="0.0" SE="0.8027729719194864" STUDY_ID="STD-Kalfarentzos-1997" TOTAL_1="18" TOTAL_2="20" VAR="0.6444444444444444" WEIGHT="16.74447612273497"/>
<DICH_DATA CI_END="1.1566750784730235" CI_START="0.1752898167134883" EFFECT_SIZE="0.450281425891182" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.06321137844683072" LOG_CI_START="-0.7562433130767632" LOG_EFFECT_SIZE="-0.34651596731496626" MODIFIED="2009-06-23 09:36:58 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="86" O_E="0.0" SE="0.4813517421671023" STUDY_ID="STD-Olah-2002" TOTAL_1="41" TOTAL_2="48" VAR="0.23169949968730455" WEIGHT="52.9248781819404"/>
<DICH_DATA CI_END="3.4970589781086274" CI_START="0.057905800636373995" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.5437029567733966" LOG_CI_START="-1.2372779292227094" LOG_EFFECT_SIZE="-0.3467874862246563" MODIFIED="2009-06-23 09:34:06 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="85" O_E="0.0" SE="1.046156988431681" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="1.0944444444444443" WEIGHT="12.624803425871605"/>
<DICH_DATA CI_END="245.80279475253892" CI_START="0.8652204761350231" EFFECT_SIZE="14.583333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.390586816462176" LOG_CI_START="-0.0628732111848367" LOG_EFFECT_SIZE="1.1638568026386698" MODIFIED="2009-07-03 15:16:16 +0100" MODIFIED_BY="[Empty name]" ORDER="87" O_E="0.0" SE="1.4411745650628611" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="2.076984126984127" WEIGHT="2.2404580727603127"/>
<DICH_DATA CI_END="2.477374703175844" CI_START="0.00823781854200097" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3939916986384896" LOG_CI_START="-2.0841877786670033" LOG_EFFECT_SIZE="-0.8450980400142569" MODIFIED="2009-06-23 09:32:28 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="83" O_E="0.0" SE="1.455694892155502" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.1190476190476186" WEIGHT="15.465384196692716"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.1930256387581935" CI_END="12.586193916367218" CI_START="0.06931823679294925" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9340518027479631" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" I2="67.70560761958941" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="1.0998944186683763" LOG_CI_START="-1.159152492709873" LOG_EFFECT_SIZE="-0.029629037020748556" METHOD="MH" MODIFIED="2009-07-03 18:57:27 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0452066052120339" P_Q="0.0" P_Z="0.9589966686259953" Q="0.0" RANDOM="YES" SCALE="574.2864850277163" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="3.5639697025279076" TOTALS="YES" TOTAL_1="56" TOTAL_2="63" WEIGHT="100.0" Z="0.05141269547327932">
<NAME>Local septic complications in SAP</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4970589781086274" CI_START="0.057905800636373995" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.5437029567733966" LOG_CI_START="-1.2372779292227094" LOG_EFFECT_SIZE="-0.3467874862246563" ORDER="265" O_E="0.0" SE="1.046156988431681" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="1.0944444444444443" WEIGHT="37.79963508293372"/>
<DICH_DATA CI_END="245.80279475253892" CI_START="0.8652204761350231" EFFECT_SIZE="14.583333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.390586816462176" LOG_CI_START="-0.0628732111848367" LOG_EFFECT_SIZE="1.1638568026386698" MODIFIED="2009-07-03 15:16:40 +0100" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="1.4411745650628611" STUDY_ID="STD-Petrov-2006" TOTAL_1="35" TOTAL_2="34" VAR="2.076984126984127" WEIGHT="31.215705737475087"/>
<DICH_DATA CI_END="2.477374703175844" CI_START="0.00823781854200097" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3939916986384896" LOG_CI_START="-2.0841877786670033" LOG_EFFECT_SIZE="-0.8450980400142569" ORDER="267" O_E="0.0" SE="1.455694892155502" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.1190476190476186" WEIGHT="30.984659179591194"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2009-07-03 18:57:06 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Enteral versus parenteral nutrition for acute pancreatitis</NAME>
<DICH_OUTCOME CHI2="1.8557342540877988" CI_END="1.1327675648163975" CI_START="0.4300443807663115" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6979543867357166" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="33" I2="0.0" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="0.05414080512065103" LOG_CI_START="-0.36648672272897553" LOG_EFFECT_SIZE="-0.1561729588041622" METHOD="MH" MODIFIED="2009-06-25 15:37:09 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7622712793928647" P_Q="0.0" P_Z="0.1455549746907714" Q="0.0" RANDOM="NO" SCALE="207.52" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="106" TOTAL_2="124" WEIGHT="99.99999999999999" Z="1.4554129454154192">
<NAME>Other local complications</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TPN</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.862368889179539" CI_START="0.008709830524179483" EFFECT_SIZE="0.15789473684210525" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4567256029427361" LOG_CI_START="-2.059990295409069" LOG_EFFECT_SIZE="-0.8016323462331666" ORDER="898" O_E="0.0" SE="1.4783313766364663" STUDY_ID="STD-Kalfarentzos-1997" TOTAL_1="18" TOTAL_2="20" VAR="2.1854636591478696" WEIGHT="11.11308945859279"/>
<DICH_DATA CI_END="3.14803388662463" CI_START="0.1926921225143971" EFFECT_SIZE="0.7788461538461539" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49803939862186763" LOG_CI_START="-0.7151360394621287" LOG_EFFECT_SIZE="-0.1085483204201306" MODIFIED="2009-06-23 09:46:53 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="88" O_E="0.0" SE="0.7126252576458104" STUDY_ID="STD-Abou_x002d_Assi-2002" TOTAL_1="26" TOTAL_2="27" VAR="0.5078347578347577" WEIGHT="13.116882436585618"/>
<DICH_DATA CI_END="1.6349768599107226" CI_START="0.4715477508092805" EFFECT_SIZE="0.8780487804878049" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.2135116104004636" LOG_CI_START="-0.32647432230536005" LOG_EFFECT_SIZE="-0.056481355952448235" MODIFIED="2009-06-23 09:48:22 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="92" O_E="0.0" SE="0.3171904098448769" STUDY_ID="STD-Olah-2002" TOTAL_1="41" TOTAL_2="48" VAR="0.10060975609756097" WEIGHT="49.27050222074425"/>
<DICH_DATA CI_END="1.720514483278515" CI_START="0.20923973817064553" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.23565833286015395" LOG_CI_START="-0.6793558320928668" LOG_EFFECT_SIZE="-0.22184874961635637" MODIFIED="2009-06-23 09:46:20 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="91" O_E="0.0" SE="0.5374838498865699" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="0.28888888888888886" WEIGHT="21.486102068170812"/>
<DICH_DATA CI_END="7.391737873352934" CI_START="0.015031798071690874" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8687465574849313" LOG_CI_START="-1.8229890669242566" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2009-06-23 09:47:44 +0100" MODIFIED_BY="Zaina H Albalawi" ORDER="89" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="5.013423815906522"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.12668549981256555" CI_END="1.4975970477881768" CI_START="0.2016595237391447" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5495495495495496" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="0.17539497527052042" LOG_CI_START="-0.6953812628223012" LOG_EFFECT_SIZE="-0.25999314377589033" METHOD="MH" MODIFIED="2009-07-03 18:57:06 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7218937615403441" P_Q="0.0" P_Z="0.24184103217847075" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="29" WEIGHT="100.0" Z="1.1703975734206247">
<NAME>Other local complications in SAP</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.720514483278515" CI_START="0.20923973817064553" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.23565833286015395" LOG_CI_START="-0.6793558320928668" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="268" O_E="0.0" SE="0.5374838498865699" STUDY_ID="STD-Louie-2005" TOTAL_1="10" TOTAL_2="18" VAR="0.28888888888888886" WEIGHT="81.08108108108108"/>
<DICH_DATA CI_END="7.391737873352934" CI_START="0.015031798071690874" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8687465574849313" LOG_CI_START="-1.8229890669242566" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="269" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Casas-2007" TOTAL_1="11" TOTAL_2="11" VAR="2.4999999999999996" WEIGHT="18.91891891891892"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2009-09-16 15:34:49 +0100" MODIFIED_BY="Cathy Bennett">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2009-09-16 15:34:49 +0100" MODIFIED_BY="Cathy Bennett" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAfMAAADnCAMAAAA94U9AAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2009-09-16 15:34:49 +0100" MODIFIED_BY="Cathy Bennett" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAATAAAAHaCAIAAAAIRoJAAAAUsklEQVR42u3dvY4dSf3G8ZFICCZw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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2009-08-02 05:19:56 +0100" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 1.1 Mortality.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs8AAAEACAMAAAB7+mt5AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2009-09-16 15:16:03 +0100" MODIFIED_BY="Cathy Bennett" NO="4" REF_ID="CMP-001.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 1.2 Mortality in patients with acute pancreatitis excluding those from (<LINK REF="STD-Kalfarentzos-1997" TYPE="STUDY">Kalfarentzos 1997</LINK>) in which death resulted after resolution of acute pancreatitis and was attributed to other causes; cardiac surgery, cancer of the liver, squamous cell carcinoma of the pharynx and intracerebral hemorrhage..</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuUAAAEACAMAAAAjhfhgAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2009-07-02 15:10:41 +0100" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.03" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 1.2 Mortality in patients with severe acute pancreatitis (SAP).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuUAAADACAMAAACUGu1gAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2009-08-02 03:56:23 +0100" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-002.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 2.1 Length of hospital stay.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxgAAACwCAMAAAC7BDhIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2009-07-03 19:00:38 +0100" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-002.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 2.2 Subgroup analysis for length of hospital stay in patients with severe acute pancreatitis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvUAAACQCAMAAAC/OmR/AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2009-07-03 18:54:27 +0100" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-003.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 3.1 Systemic Inflammatory Response Response (SIRS).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqkAAACQCAMAAAAcEgK5AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2009-07-02 15:55:30 +0100" MODIFIED_BY="[Empty name]" NO="9" REF_ID="CMP-004.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 4.1 Multiple Organ Failure(MOF).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs0AAADgCAMAAADPPKtyAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-10" MODIFIED="2009-07-02 15:55:30 +0100" MODIFIED_BY="[Empty name]" NO="10" REF_ID="CMP-004.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 4.2 MOF in Severe Acute Pancreatitis.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs4AAADACAMAAAAjpxVHAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-11" MODIFIED="2009-07-03 07:47:32 +0100" MODIFIED_BY="[Empty name]" NO="11" REF_ID="CMP-005.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 5.1 Operative Intervention.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs0AAADwCAMAAADM6qnpAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAWxElEQVR42u1d267tOFbN2WehCRICxBGllngo8cLX5I33/gd+AYmv
6G8oiQd/Tb+ghlLTApVUIFD3lDaIvXP1ZdqeTpzEK2sMVZ21dpbvHp6edkacL9QBwE3whiYAwGYA
AJsB4DA8GipLP/xrxJ9MKp4pycFkovedObGua272N7cdenNSoZ6+Ki2xOV7TPt+aunb/yMLnfn9Z
bT/LYhK/pYZgU2imKo82x7qZKz589J+Duv/8nAg/Bxkvao3zENV0QnQny5Mra+frjWan8s2zuoGq
NOk3m4Fqn/98jHgzkNVM09QwVU0/jldMccNI0dcsr2DBlK/PALvylxXvmaryaLt5nEqbYESbvalf
PgXNfR26m6ZrnrzNVaXdPY2+T6zJ+ifp5/QEZHmWrg9vzIkL0htV5a3hJjLxZeHw49PzeV7ym3B9
NDlUqMpN2JwxwBus89Dk7Vn1funqp3EtWq3KW7uDvR/9rT5sG2M1W0nD2YmG0d3L51k0OV8zLnrX
Ap5fvOeryheojoDbAHe2AbAZAMBmAACbAQBsBsBmAHhG2DqNaS/Qk6SldgbnGPmQOSS0zbJEzovQ
y6UoTVaZ6njHy1iXQ3Gvk/wcultVDFbUrhv1gUJxPC3lHHbcw7V/CmQ+Xf3byafXYgeb+0mLWqYX
DgXDG2HSRA+D2zXvKyWrTTWfTV9YdZNt6bGhzcyE8Cd/rJ5+L6h+LXbY5rk7FxGqscZf7yiDO/te
2hpyCToKh9c7RJac2GSHxxp31S9HFbGrcDYVpjTZTKrzkO+FGnZzVv4zLSbzzIHV6K7dF+fJ3p4U
0rOnEftto3m+pBab/Obp7qPjO/ReOaZiGiuGZxCWSIJmuFfdhg4FyFFF7PjDGMZkVLP6ZDWprkLe
9Vu/VHJH58zS7k4iTq/UmUw3jx2ZuNVvx6NKLXaw2XSSJsckRFBBDJOb3hON+VHD3s/JeK2T78Dq
yZoSnZKJV9Kdh93unP4K5AtSk4+TZ54RznAytcRWZ9dih6cxeRlFlSuNofQ8/SoajahQtAO7k5Wt
y0YP2XHPQiPQz+urIHxvL7iHlbpygdPrKrG1y06qxSa/uVzHd5DyT9Jh5YaNYtGzIVkpVTNK8SYb
pB3MvbUvEA3RR1I0Wx/HNXt3m5qoRbmn4fvA+Z0TK0bvmKk+0QrZwWGE0uxUEB6UbNAOiq6yHzMI
Wnxx0ecHb5Zvvesv9K6gtbYSvMFalPvN/Sz/nTcCjWe4PJ/IimHWSca4pQwDxP1mMZupPHLMNYOE
31ycbDZVqUncxgomLaMdOH6bzdeMVwONLNuViVeZNC+ohRo6fXNRRr2JRXiiR4M2bV4V11Cz5OjN
M1S8jVo8VFwu6iPT/nEmh6C83iBzZeDZEwAAAAX+7tzsHrDNwIE4l15QhAL3AdgMgM0AADYDwIGr
QOs70/rv9IXjbjzHHfwpoXENMH7w3iUB56I7mWoSpFw1/Drks5wvkDJdIYfPyEKKVv5yXL+njuiD
ON59Ll3P5rB3mTYSbx4MNH/Qcn0jmXMEYV0wL3ymTG4dslkuF5gyZCbbdrg5kJiiZ2TCuMSH98Fz
2eaFv/Po56EpxnFN9tfBFvDc+L51IS415nlQlu1cODpYEY2KsiwtQ75eqhSpICLXMc2B6OOfxKun
3xF+SGSeRz9ZVsP/SnPQwLpQd2RDbmR7JHzVAUbVK0uVI9bqA1Nw9To2C3SksH1I24aq2Vzvvyi6
gri2Z6ghAPtlINYVV12vnL9E+zyqW3oas7vHka7iRFcHPBo7df6oYacUxNL7zfVmhaCC1qRVq17K
nCMhqvWBfvnVAJtp8C2mzQxnZyNie8ntQ6b4ZM7PeQtdUWza78Xv9Cc4N1s+dx/o8SZM1QnrHJ+x
+NgpjpslM19WL84W8qXcDGmKoGGzZ7Ut1h+eM8HjPsZ0VfI0xOubZ9UL/GYed2qSqRIH8xIPUShb
TCaxlYIUnQtBXI5vstftg/YBffPzuDb5PezmcPKzBriz3Rydn8oVa9zTAK4FbfrpRTwJ2GYAbAYA
sBkAwGYAqL0KXERHsYUzxS65Qrq0LHjrmn2HEnlrshphsKA3Fu6vc+fdkosomsV6CGJlp/FDJfrh
/dE+m/OyXI4Ix1whXVoWvI3MmbQ2ZpkJrxEGS3rjeEN1gmaZknrnThYrr9enwcbx5jigP57BNi+t
Zz2wEDaB+0BDXAVas+FI/zsdketeFljUTGo4pHq4MewyRTXah/dHOD+J+CEV6Wv3v5Wp8JBbPjWS
2x7pfEinlVY0DL/M8uVCUUp3awt9ECtD8l7ge/Wie88FDjMkxbuImGINyVSBBXsYxWVKzEN4zF1M
3xxxpbfUQzdgD++PY/yCin6zZjXUtpTlyhLNAi2JjRQLvKEedH9pZw02U5TQZP8+mRnX2rRhmg9y
MdTCe5VvnOZrpXq0b5oPwJtXVeKQ0ez+Lopmb03mnUsh8TfemiODzEW+y6jNXR0KCp57CzwNVwic
F95uWNyl09IokeWqKlLVJMFW5oK+OaZZ9n916+E6K27jkqK5juuPNgF98/W7MFsVzU9geKFvfj06
N5PIHT0NoJVtGKqSyusAthkAmwEAbAYAsBkASleBvNyWnS8ExwZfpZjlTnmAs7Y8qvObvUNT5Rxt
bXJH5ec3T/dYC9XOXp2b0Te/X7i38PB7hxPHS16qmNXdI+OS0aEIz4l2CQ9XnrmlP795jVOodvbr
DH1zJ5ytT+7DJMuYP1sxK1vSfDDuSgLuOTBOOL95c71IP4JVx0af2Ft+5l/taz+cy5NHxnpwK4It
Vp0Nri6qUhucYjul/AeqVa9UtoV1PmfOfLevnXwv8JEp46kK5kyjXTasNOfQrWUsO7+ZFtec9kxK
yoj8Qs8FpiaQri0LcE43MWXXE8JLBUqeGrAeMCmuQpvUvPLu8lu0pYiearAzHzEAN6Zar1XSby7i
9MO3r2aaHTYPXpi4dr6+eXKc+hx89ctSlipvr9cmtXOqdNA3Oy6gL2u+WDF76XNbyvObU/rmTJxy
tTP0zQKgb24MOL/5AL8ZuIzOp0Z7kT0N4CKvZtNP0DfDNgNgMwCAzQAANgPAplWguB/JTQhnlVlU
Pr9ZE8o5VyR6fnOsUf0WlPTNzvnR1h/2rzi/uSvQN7tBThfOKrOofH6zJpT946yGzumbvRc/U0bf
7Jwfvf7h/Nq2vvn9nN0zUd+81H40FEyZ81pPaCFqNlnaNDZZlULkmD/rj8gDNNd0U7jnPZ/f/DW1
IU6HsDlIe2A0vcRTC5UmkPyrr4P+U0lHI2TmruzpsdNNznwv8P0cH+eR8hDl87CltuMzBv4x79nW
UYH1JSvTNy/SUS6vdVJ2elE3aY3mKdmQ3KpZCdvx9oGO8JuVWefOWnYfsC06FZ3SOSSToUPa8DZ7
GkmSFNmyJ/IO6vnGvK7euJhnGxyNVBVe0jGM6ZvZt8icnMCOJ92VZGbdjzs01ly71hd1U0u2efY6
l1ceTC+nonUiFIWzJ4iPlVmUlkQn+VXqm20qkcZFzeqb3Yx9C50o1lXddDG+0N71EXDWZAF9c4mn
ATRB57ZcsdusAmGaLwD0zbDNAAA2A2AzAIDNAHDaKlBxTykmmz1hEaJ7/WVtnYYi1bX6S3sUnN+8
nhC9nsmaPr9ZPvtZqW/uXvvOdiA4EvSyZ7SQ6qDlDToN3p8qBa1Tcn4ze+2cO785cvazQt98zlnk
j8bYvN7cmlsiqW4+Zds+p3zYcxDzvlRZVhrWnXhEPWOpHmlvR2la+Ksb6oeC4h3DZpYOiWLSTZtH
gXb+vo2vWrEobSfOfCx6OjP5Pvkxj43tao13N1Qj5zeXWJHbS/nTAgffDSjTN6va0NWXsntedFMd
de1pQw/lmD7ALLYApVQ/RQORNGp9c/pNEXIe5J0XXdO23nwV6DXD3YwwV63SsrIjvqYA9+0oFd6U
NpnjbfTMepcKxz7zLgZNBeAt+XEhmV9M3zyezLCqYScLQ9ZhD43LZo8pi1LfzNb7FrXnN0s5xE53
nvyL5NnPS09C3ww07clD37zL0wCu8eRPjPaCq0DgRF9p454E5ljYZgBsBgB4GsBN8d4InWCbgXva
ZnZXE5Etn4tOBs6+Nb5QwqsLz9FTONerW85vDhTMlkDU1jdL+upd+uYXOr+ZOp0o/oKTgbM6vkIJ
ry48kyWmFzm57fzmQMFsn5hkpyjoq7frm+9/0usjajl46JP57OZ871/bTJScT7aGL0xtT7nlwyyJ
E1lsOW+xci9Nxfvq/d3SUaTzYC8Z0dzIHHbQmyJEsvFymlnAyVITSJnLdfTN9XuJvFXgxSQIdBok
NydZkyeL70Y5dg7LawzGniqYTFkTXtH/ft0L9c3KA+ukUlKXOPv5il5qzm/uui13SY8/izxLU5rf
AVK13BSngOO8+hf0xKGSx6ikq5nTpZtxBq/ymwsOE35eFL3sRzZ1whPtW89vrjDd37KXyvCWdu/t
+ZNabiYunVVSr2fwU5VV0MHVLWJpPqjO5/bSY0aDtpnY3qzzPNaLlLO5HEoL4lZju7e+7fzm2AnN
kRShb1YC+ubncYCgb97qaQAX+0wnRXuBVSBwHaBvhm0GALAZAJsBAGwGgBNXgcoNSUk1ywcvRVh5
i5KparKKVPfpmzvvrpR4frO7my2c/azSNx/dRY2xWSmAFVWzcRVwHTLn5UH2R61kFanu0zev78hd
NydS6mc5P52+uXIXvbe3IxacrU/Wgc2RJxcobccuwXxwbKFAguqkSnvLXRCI9tQrcaRocdG/KiL9
UK+lyj2NKb9tTy5cejOKDmksXap79M2kYTXtGQrKLipvuXdFpBbObybnKwk/3EehtV/AvlPfvNHt
cvIrfDLlQOq0tAp0px2yngS9rWZlv4B9p755O/WsFSpeiR5h8/quk46Ev6KNjwbdo28uOcaZSRHp
JbvozZuy7KW2e1Iw37FVqu7C7DgMuiTq0vqpSK9pWx6SBzY9m+Me5Jw5xfloh+CYXCoku0/fnP7V
Ld78gAG7/pFa33x/QN/c2mwBfXMdTwN4YucH+uYO+uYG91i2/AR9M2wzADYDANgMAGAzAIDNANgM
AGAzAIDNAAA2AwDYDIDNAAA2AwDYDABgMwA2AwDYDAAuvvvuD1dm/xVyfaAa/urH//rV+/9ZF/72
17DNwHPiVz923W//9I+uK4Blmvvh3+WxxPUBxX66+HGlH0MMQU3/+X0JNv70EfbkJxvn4vVzwUzF
VMcqug3T+bmtmc5tYLeLlPSaml14Kzs7ObdS1h924fpa9d5jmX/5+e/vvvvzf2nAbzZm/N/mttcJ
/WeAkcpDaLd756btTybz+mEVokqq/ZCcMcZIP0+5rZnO30xunBin1HaLmTA5p1J2M9uFu5zKHz7z
j923z89///lLA7bZGf29bYqXlvaMtWXBh0tmsROnk/mQVG0racoyrTFBmWwRxcJd5Wb8fdf99O2n
rvv2H9/+7Let7GmMo9+Ms6VjFexAfX86w5J9Xtu9Mel6Vsqt31X4dCecTeZffhC5G///6Z9/0Qqb
nT6LtdfI8r6BJjWHpjqNZt/6mbxlr9MuSbMbKdw1+Ffnr/9skM1CLw59NLmRH5b7w6q00JSzdYsP
v1MHmLZdsqZ58t9assEx/MP3H/98m/7/m9834zenLIM5e41X4uiOFOqPSNwcWuo+Qukp33Sl2jDN
Xfe7738zOhrfuv+5yG0uPOtothWLW7k0pOl7c2HDmrFs1lr0gvFkitaAw/pkiGUkSn5udVq7d17j
tkJhh85/8fPw+eUv//uqIrzJzrKZmq/vHV/x84JZgjhLPvvaZS09la9mconKrC21GNGwXbamOq/z
erdSkcyawO//8fPf7/7wm8tKUHBGqLbtWrQbT4Jk06XHaROt/ic/d7/4tz9Wl/nkVeC23QOQeZ8n
vY3MTVjn7//aIXPDthkAigcnzm8GALAZAJsBAGwGALAZAMBmAMjBurM9vdVofY95F3yTcey7vdbX
I1PlZDuqnyzQCJvbfF0zW69Hrlo6slIH7utpMPP0NtDhm3e5W3/4CCOGrE66+gbUojDIfEfb7FpD
8g0ie2+NX4wmHWI6D7f5s3UGm19kFSj0M3HUrB3GivlF9nUdDaJhehk/gLva5i5YGIZ/cEjy57Jx
BDfj1djMZPOWUnb4QE/jENMMvJynERjhTwu8+M5dwlY3T2a4Fy9im2evYXApV6/SdiY8x2J0Po+x
nTyu17jyzvBUYMJ+833ZTN6/NP9neRckBTmOEgft0B2WLtCwpwEAYDMAgM0AADYDAJ5yfXVs2/hU
x6ofMBkLthm4Dx4B0/W6Zmmo+HGWvespwCQrdkPMl5bNXzeV8ZYkSemuiYZ7bWsQO10raak0Xhm4
g2T0Sdm8GyROBY5KiYLbcDQzeg3M2SnFSpfJGTBCECddssOFpXHLMLAfZH5yNs+332gyVUOXLg+B
EC8PbXyat/XJkM+/eAk/M4wcK8cRzkft/Ug5IQjtG2Rr6psSvYPP3HVbb/HzdQFjE3uUzaHCef06
0tr7YbFoNE37gURpnuPZ1jJRzPCy47ysA8KOJDslKUpOngXT6qQIpfHLcF/TTLdbBT5048MVMnPK
lpE4N3sKTCoYoUt2FHXRF/+XyhpLLI3tGQ1CFQj6n9LToJkZnCc4V5gnQtoSK4cplfsHJcOfKZxW
gCf1mxUPzRXQSeCCPbevP5Mz/ycjJccYySWIjhTB7+F1CQnx6PPvaSQ26mSPkle5KHX2V4lBlMjS
j8IFFpgSdaGcw6EKe0Pf+cBYdG45HpEpf1U4L87loggevjnCYOsvV1yv1w9/rs2cwBOtuJOM4xo0
uoFG8z6Lp41OP5Dr66jHYt2V2MGW/PoRMwzSgSt7vbtlOiRtiSOHrGy6s50pYx2rpk2lNDccoSE0
hXdqCVO+8VjFPVKNKdL2S7C/5kYpvrPNHziDzCVrx0M2l16c5WeFKesR2ug3b3dwKtHlIJeLKhbx
vnTONxFV65mKnfFA1wESwZqdw1IFg4YOONJanguwGbiPTw82A5Lb/JwL1C/k14HE6GV7rsHNYA52
bS0Zm5SrtxFqa6XUemZvUxJbc5HV3iqJzB+Wvca4ZL957nnVfjPHxJOFLPDZLMn4KZGvoE22P1il
Z/b3UHdoxoDn9Zuns5jXY5ztI5p5ltZLpzmH5zjPidg/zulydBDR5mG+00oAT43o+c2WyHm8feze
J4qe5uzyxlFK23poW2WccjkCNhbomaUBgidJXozNGRvp6PAdLTOp93ZEQbHvaE85iM+OdLgNAujY
zAke5dbAnFoes94HIGEOSI8yAHgkJmW1s+kK3zjKO1KMCSpyexnkPg795z+mLPhH+PFN8c774stS
GhPqzBxLSLDM09A+b0GhO8tJIoZbJCwcc692bsHjI2G2BRd4ZwrTGZMwU2K9NvqbxNBBJTd9LOwk
Rzxn/2V9J09g50RaE6Z1c4QHVR6LRWA/1y4hmQviePXA1sZmG933o8Hsp+/LH+sVh419rZSyCSZt
M3meRued1NzJj6uS81U49Nk95JnsJWPqaRA/Ttoix+LgFSc7yWxZR89S9qbIdtZLadOeRovYtccG
01zoOJvZSzC9CalmnI/FOw5DFqZkOdCmExO8C5t32ViQeYMjnJznTS9QMWBfYUpdNsHbsBm4wNNQ
rNnOTEm/CgSA0FHwzWPfpcxtdN1WnFLRQhC2Gcj5G/3KpckbsC5Z/oG9qyyyT53SVjrjNHLgPoCn
AYDNAAA2AwDYDABgMwA2AwDYDABgMwCAzQAANgP3xP8DXw1HBjHOMxsAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-12" MODIFIED="2009-07-03 07:59:59 +0100" MODIFIED_BY="[Empty name]" NO="12" REF_ID="CMP-005.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 5.2 Operative intervention in SAP.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAr0AAADACAMAAAA+2SvcAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-13" MODIFIED="2009-07-03 08:09:56 +0100" MODIFIED_BY="[Empty name]" NO="13" REF_ID="CMP-006.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 6.1 Systemic infection.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs0AAADwCAMAAADM6qnpAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-14" MODIFIED="2009-07-03 08:09:56 +0100" MODIFIED_BY="[Empty name]" NO="14" REF_ID="CMP-006.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 6.2 Systemic infection in SAP.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuMAAADACAMAAACZBJ0nAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-15" MODIFIED="2009-07-03 15:16:22 +0100" MODIFIED_BY="[Empty name]" NO="15" REF_ID="CMP-007.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 7.1 Local septic complications.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtQAAADQCAMAAAAQ/Qb9AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-16" MODIFIED="2009-07-03 18:57:28 +0100" MODIFIED_BY="[Empty name]" NO="16" REF_ID="CMP-007.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 7.2 Local septic complications in SAP.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvQAAACwCAMAAABXVAp3AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-17" MODIFIED="2009-07-03 08:11:24 +0100" MODIFIED_BY="[Empty name]" NO="17" REF_ID="CMP-008.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 8.1 Other local complications.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs0AAADQCAMAAADLRqzfAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-18" MODIFIED="2009-07-03 18:57:07 +0100" MODIFIED_BY="[Empty name]" NO="18" REF_ID="CMP-008.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 Enteral versus parenteral nutrition for acute pancreatitis, outcome: 8.2 Other local complications in SAP.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuMAAACgCAMAAACR8JJ9AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-10-07 10:18:17 +0100" MODIFIED_BY="Cathy Bennett">
<APPENDIX ID="APP-01" MODIFIED="2009-09-16 15:06:07 +0100" MODIFIED_BY="Cathy Bennett" NO="1">
<TITLE MODIFIED="2009-05-19 14:21:53 +0100" MODIFIED_BY="Jan Lilleyman">MEDLINE SEARCH STRATEGY</TITLE>
<APPENDIX_BODY MODIFIED="2009-09-16 15:06:07 +0100" MODIFIED_BY="Cathy Bennett">
<P>Search strategy (MEDLINE 1966- to November Week 3 2008)</P>
<P>1 randomized controlled trial.pt. (269477)<BR/>2 controlled clinical trial.pt. (80776)<BR/>3 randomized.ab. (177355)<BR/>4 placebo.ab. (111337)<BR/>5 drug therapy.fs. (1318399)<BR/>6 randomly.ab. (128722)<BR/>7 trial.ab. (184716)<BR/>8 groups.ab. (890308)<BR/>9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 (2386281)<BR/>10 humans.sh. (10826325)<BR/>11 9 and 10 (1953119)<BR/>12 exp pancreas/ (84903)<BR/>13 exp pancreatitis/ (37139)<BR/>14 panc$.tw. (173342)<BR/>15 or/12-14 (200177)<BR/>16 exp enteral nutrition/ (12820)<BR/>17 exp parenteral nutrition/ (19417)<BR/>18 exp nutritional support/ (32587)<BR/>19 enteral$.tw. (11072)<BR/>20 parenteral$.tw. (36489)<BR/>21 TPN.tw. (3414)<BR/>22 PN.tw. (6162)<BR/>23 EN.tw. (20079)<BR/>24 or/16-23 (85483)<BR/>25 15 and 24 (2919)<BR/>26 25 and 11 (571)<BR/>27 limit 26 to yr="2004 - 2009" (175)<BR/>28 from 27 keep 1-175 (175)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2009-10-07 10:18:17 +0100" MODIFIED_BY="Cathy Bennett" NO="2">
<TITLE MODIFIED="2009-05-19 15:04:48 +0100" MODIFIED_BY="Jan Lilleyman">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-10-07 10:18:17 +0100" MODIFIED_BY="Cathy Bennett">
<P>Search strategy (EMBASE 1980- 2008 week 50)<BR/>1 exp randomized controlled trial/ (163768)<BR/>2 randomized controlled trial$.tw. (23434)<BR/>3 exp randomization/ (26367)<BR/>4 exp single blind procedure/ (7858)<BR/>5 exp double blind procedure/ (70768)<BR/>6 or/1-5 (216794)<BR/>7 animal.hw. (2211384)<BR/>8 human.hw. (6476512)<BR/>9 7 not (7 and 8) (1981360)<BR/>10 6 not 9 (211800)<BR/>11 exp clinical trial/ (534057)<BR/>12 (clin$ adj3 stud$).ti,ab,tw. (113037)<BR/>13 (clin$ adj3 trial$).ti,ab,tw. (121139)<BR/>14 ((singl$ or doubl$ or treb$ or tripl$) adj3 (blind$ or mask$)).ti,ab,tw. (92614)<BR/>15 exp placebo/ (121040)<BR/>16 placebo$.ti,ab,tw. (108265)<BR/>17 random.ti,ab,tw. (84865)<BR/>18 (crossover$ or cross-over$).ti,ab,tw. (38930)<BR/>19 or/11-18 (834581)<BR/>20 19 not 9 (805886)<BR/>21 20 not 10 (608448)<BR/>22 exp comparative study/ (319229)<BR/>23 exp evaluation/ (53603)<BR/>24 exp prospective study/ (78778)<BR/>25 exp controlled study/ (2811967)<BR/>26 (control$ or prospective$ or volunteer$).ti,ab,tw. (1722211)<BR/>27 or/22-26 (3848159)<BR/>28 27 not 9 (2744044)<BR/>29 10 or 21 or 28 (3077253)<BR/>30 exp pancreas/ (37058)<BR/>31 exp pancreatitis/ (29788)<BR/>32 panc$.tw. (125868)<BR/>33 or/30-32 (140055)<BR/>34 exp Enteric Feeding/ (8044)<BR/>35 exp parenteral nutrition/ (17910)<BR/>36 enteral$.tw. (9682)<BR/>37 parenteral$.tw. (29889)<BR/>38 enteric.tw. (16233)<BR/>39 TPN.tw. (3038)<BR/>40 PN.tw. (5694)<BR/>41 EN.tw. (19185)<BR/>42 or/34-41 (84474)<BR/>43 33 and 42 and 29 (1333)<BR/>44 limit 43 to yr="2004 - 2009" (557)<BR/>45 from 44 keep 1-557 (557)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2009-06-26 18:38:22 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2009-06-26 18:37:35 +0100" MODIFIED_BY="[Empty name]">Cochrane central update</TITLE>
<APPENDIX_BODY MODIFIED="2009-06-26 18:38:22 +0100" MODIFIED_BY="[Empty name]">
<P>Database: All EBM Reviews - Cochrane DSR, ACP Journal Club, DARE, CCTR, CMR, HTA, and NHSEED<BR/>(2004-2008)<BR/>1 exp pancreas/ (637)<BR/>2 exp pancreatitis/ (590)<BR/>3 panc$.ti,ab. (4089)<BR/>4 or/1-3 (4362)<BR/>5 exp enteral nutrition/ (1046)<BR/>6 exp parenteral nutrition/ (1279)<BR/>7 exp nutritional support/ (2198)<BR/>8 enteral$.ti,ab. (2434)<BR/>9 parenteral$.ti,ab. (4576)<BR/>10 TPN.ti,ab. (560)<BR/>11 PN.ti,ab. (321)<BR/>12 EN.ti,ab. (1719)<BR/>13 or/5-12 (8248)<BR/>14 4 and 13 (231)<BR/>15 limit 14 to yr="2004 - 2008" [Limit not valid in DARE; records were retained] (59)<BR/>16 from 15 keep 4-50 (47)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>